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ABSTRACT OF THE DISSERTATION
Chronic Hypoxia Induces Epigenetic Modifications In The
Fetal Rat Heart
by
Andrew James Grant Patterson
Doctor of Philosophy, Graduate Program in Physiology
Loma Linda University, December 2011
Dr. Lubo Zhang, Chairperson
Heart disease remains the leading cause of death worldwide. As a result of
studies done by Barker and associates, our awareness of the significance of stress during
gestation as a risk factor for heart diseases has expanded. We now know that events in
utero can significantly alter gene expression patterns in heart tissue leading to increase
susceptibility to ischemia reperfusion injury in adulthood. The focus of this project was
to elucidate the role of chronic hypoxia in the programming of the cardioprotective gene,
Protein Kinase C epsilon (PKCε) in fetal rat heart. We used an animal, organ base, and
cell culturing with the rat embryonic cell line H9c2 to determine the molecular events
underpinning the heightened sensitivity to ischemia reperfusion injury of adult offspring
exposed to chronic hypoxia in utero. We determined that chronic hypoxia directly
represses PKCε expression through increase methylation of CpG dinucleotides for two
SP1 binding sites located at proximal region of the PKCε promoter. Previous studies
using reporter gene assays concluded the region encompassing both SP1 binding sites
played a significant role in the activity of PKCε promoter. Chromatin
immunoprecipitation (ChIP) assays further verified the functional significance of
methylation for both Sp1 sites in reducing SP1 protein binding. In the presence of the
DNA methylation inhibitor, 5-aza-2-deoxycytidine, binding of SP1 to PKCε promoter,
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promoter methylation, and PKCε protein and mRNA were restored to control levels.
Connecting epigenetics to chronic hypoxia in utero led us to further investigate the
underlining mechanism of hypoxia-induced methylation of PKCε promoter. The
dominant pathway of cellular adaptation to hypoxic stress involves the stabilization of the
Hypoxia-Inducible-Factor 1 alpha (HIF-1α). We found blockade of nuclear accumulation
of HIF-1α did not restore PKCε mRNA to control values. Next, we found the ROS
Scavengers N-acetylcysteine and 4-hydroxy Tempo protect against hypoxia-induced
repression of PKCε gene activity, which linked oxidative stress to PKCε repression in
fetal hearts. This project has demonstrated that chronic hypoxia directly regulates PKCε
gene expression through ROS mediated epigenetic repression of PKCε promoter, which
leads to long term programming of the fetal heart.
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CHAPTER 1
BACKGROUND
Introduction
According to the World Health Organization (WHO), cardiovascular disease,
namely, ischemic heart disease and cerebral vascular disease are the leading cause of
death worldwide (WHO, 2004). For many years, environmental, heredity and lifestyle
factors were seen as major contributors to cardiovascular diseases. While changes in
adult dietary practices and lifestyles in recent years have contributed to the increase in
incidence of coronary heart disease, it does not predict who will or will not develop
cardiovascular disease. Recent epidemiological studies have correlated an adverse
intrauterine environment with an increase predisposition for developing cardiovascularrelated illnesses in adulthood. Most notably, published studies by Barker and colleagues
showed that regions in England with higher infant mortality rates and low birthweight
had the highest incidence of coronary heart disease decades later (Barker et al., 1986 &
1989). Similarly, The Dutch Family Cohort study found that offspring of pregnant
women exposed to the Dutch famine of 1944 had increased rates of cardiovascular
disease (Roseboom, 2001). These studies led to what is known as the Fetal Origins
hypothesis, which proposes that adaptations made by the fetus in response to
undernutrition causes permanent changes in tissue structure and function. This
programming in utero predisposes the fetus to cardiovascular disease later in life (Lucas,
1991; Barker DJ 1990, 1994 & 1997). In utero stress has been expanded to include
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stressors such as prenatal exposure of hypoxia, nicotine, drug use, elevated steroid
hormones, and high altitude (Zhang, 2005; Meyer, 2007; Seckl, 2008; Mao, 2010). The
focus of this study was to examine the initial molecular events that occur in response to
chronic hypoxia in the developing heart that predispose offspring to increased
susceptibility to ischemic reperfusion injury later in life.

Hypoxia
Oxygen is an essential substrate for cell survival. It acts as a final electron acceptor
in the electron transport chain (ETC). In humans, oxygen tension varies from 100 mm Hg
in alveolar arterioles to between 40 and 20 mm Hg in systemic tissues (Webster and
Abela 2007). When oxygen is scarce, the ETC is compromised. Since the ETC is
coupled to oxidative phosphorylation, ATP (Adensosine Triphosphate) levels drop
significantly creating energy disparities within the cell. Hypoxia ensues when the oxygen
tension is lower than physiological levels and the demand for oxygen exceeds the supply
available. Hypoxia in non-reproductive tissues, as identified by direct measurement of
pO2 values and/or significant induction of hypoxia-inducible genes, suggest oxygen
tension between ~20 and ~7 mm Hg as physiological hypoxia [Gross et al. 1995; Raleigh
et al. 1998; Fueck 2009). Researchers commonly use between 1% (~7 mm Hg) and 3%
(~21 mm Hg) oxygen in cell culturing to mimic hypoxia (Ivanovic, 2009). For in vivo
studies, animals are typically subjected to between 8% and 12% oxygen in order to
significantly reduce arterial pO2 to comparable values (Lawrence et al. 2008; Reynolds et
al. 1996; Mitchell and Van Kainen, 1992). By comparison, fetal arterial blood pO2 ranges
from ~30 to ~20 mm Hg (Fisher, 2007), suggesting normal fetal oxygen is close to
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physiological hypoxia in adult tissues. This implies that fetal development exists in a
state of relative hypoxia as compared to adult oxygen tension, and also that fetal tissues
have a lower threshold to reach a state of oxygen insufficiency. Interestingly, short bouts
of hypoxia naturally occur during gestation when the uterine artery contracts or becomes
compressed, which reduces the amount of oxygen delivered to the placenta.
Additionally, since the placenta serves as the major interface between mother and fetus,
its development and oxygen consumption also influences fetal oxygen supply. Changes in
maternal pO2 and/or abnormal placental development or metabolism may reduce fetal
arterial pO2 and result in fetal hypoxia (Jensen et al. 1999; Myatt, 2006). Under hypoxic
conditions, the fetus compensates by altering fetal blood flow away from peripheral
tissues to vital organs; shifting from aerobic to greater utilization of anaerobic energy
pathways; and the induction of hypoxia-dependent genes necessary for survival in a low
oxygen environment.
Cardiogenesis involves the formation of the embryonic heart. Once the heart is
formed, it undergoes a stage of rapid growth and maturation during fetal development.
The formation and subsequent maturation of the heart are tightly regulated processes in
which oxygen tension plays a vital role. Interestingly, the fetal heart is more resistant to
hypoxia induced cell death than the adult heart due to its enhanced ability to increase
glycolytic flux (Ascuitto and Ross-Ascuitto, 1996). There is increasing evidence
suggesting that low oxygen tension in the fetus is essential for normal heart formation
and maturation. The expressions of hypoxia-induced genes, such as hypoxia inducible
factor 1 (HIF-1) and vascular endothelial growth factor (VEGF), correlate with
angiogenesis, vasculogenesis and fetal heart remodeling [Compernolle et al. 2003;
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Sugishita et al. 2004a). Although physiologically “normal” hypoxia (lower oxygen
tension in the fetus as compared with the adult) may be beneficial in normal heart
development, pathophysiological hypoxia (lower than normal fetal oxygen tension) is
associated with significant adverse effects that can lead to changes in structure, function,
and gene expression in fetal hearts, which may persist throughout adulthood (See Figure
1). The role of hypoxia in fetal heart will be discussed in more detail later.
Beyond fetal development, hypoxia has pathophysiological consequences in adults.
For example, when arteriole blood flow is occluded from plaque accumulation, emboli,
or vasospasms, the tissue supplied by that vessel become ischemic. Lower perfusion
significantly reduces the amount of oxygen, glucose and other essential materials found
in blood for that tissue (Reneman, 1998). Thus, extended periods of oxygen deprivation
combined with inadequate nutrients may result in tissue death. Tumorigenesis is a further
example of a pathophysiological situation where hypoxia plays a vital role. Tumor
formation is characterized by clonal expansion of abnormal cells. Initially, the unabated
proliferation outgrows nutrient supply provided by blood vessels, thus producing an
environment lacking adequate oxygen. Then a subset of the colony adapt to this
environment by up regulating anaerobic pathways in order to sustain cellular functions
and growth in a hypoxia environment. Eventually the tumor mass recruits vascular
supply through angiogenic mechanisms for long-term nourishment and growth (Papetti,
2002). Oxygen availability is vital for both physiological and pathophysiological
processes.
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Figure 1. The effect of hypoxia on fetal heart development. 1. Insufficient exposure to
“normal” hypoxia reduces the expression of key genes (i.e. HIF-α, VEGF) needed for heart
and vessels formation. 2. Adequate exposure to “normal” hypoxia ensures expression of
hypoxia dependent genes needed for vasculogenesis, angiogenesis and fetal heart
remodeling. 3. Chronic exposure to moderate “abnormal” hypoxia can lead to
programming of cardioprotective genes, which may decrease the ability of heart to adapt to
stresses later in life. 4. Exposure to more severe “abnormal” hypoxia can significantly
affect fetal cardiomyocytes development, which can lead to cardiomyopathy.
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Formation of the Myocardium
Heart Chambers and Vessels
In order to understand the role of hypoxia in normal fetal heart development it is
necessary to highlight the key events in normal cardiogenesis. Our understanding of the
events that lead to the formation of a functional heart in vertebrates comes primarily from
studies done in chicken and mouse models. Although there exists differences between
species, the major events are congruent. Arguably, the first significant event in
myocardial formation involves the formation of the primitive heart tube (Sedmera et al.,
2000). Cardiac progenitor cells from the primary (later become left ventricle) and
secondary (later become right ventricle, outflow and inflow tracts) heart fields
differentiate into myocardial cells and fuse along the midline to form the heart tube
(Fishman and Chien, 1997). It is during this event that peristalic contractions appear
along the heart tube. Once initiated, the heterogeneity of the heart chambers to be formed
becomes apparent with regions destined to become atrials and ventricles contracting at
different rates. Structurally, the primitive heart tube is composed of a myocardial
covering that is one or two cells thick, an acellular cardiac jelly, and endocardium
(Fishman and Chien, 1997). After the heart tube is formed it undergoes looping and sets
the framework in which the chambers can develop. After looping, changes (known as
trabeculations) in what will become ventricles emerge within the lumen. Trabeculations
are fenestrated sheet-like protrusions into the lumen that initially serve to increase the
surface to volume ratio, allowing growth of the myocardium prior to the establishment of
the coronary circulation and the separation of blood flow before septation (Sedmera et al.,
2000). The heart then undergoes further remodeling with growth primarily from
increased cellular proliferation and compaction of trabeculae. At the same time, the
6

coronary vasculature is established to meet the increasing demands brought about by the
growing myocardium. Angioblasts form the primitive vascular plexus. The vessels
undergo extensive remodeling and patterning and mature into the coronary artery tree.
Evidence suggests that hypoxia may be the initial signal mediating angioblast invasion of
the embryonic heart and subsequent formation of the coronary vasculature (Wikenheiser
et al., 2006; Nanka et al., 2006). The establishment of the coronary vessel network
ensures adequate nutrients are delivered to the myocardium allowing sustained growth
and maturation.
The functional unit of the myocardium is the cardiomyocyte. As previously
mentioned, cardiomyocytes originate from cardiac progenitor cells in the primary and
secondary heart fields. They differ from adult cardiomyocytes in size, organization of
myofibrils, and proliferation capacity. Fetal cardiomyocytes are smaller in diameter and
are normally mononucleated, whereas adult heart cells tend to be larger and often display
polyploidy (two or more nuclei per cell). Fetal cardiomyocytes have fewer and less
organized myofibrils with poorly developed sarcoplasmic reticulum and the T Tubules
systems as compared to the numerous and highly organized myofibrils found in adult
cardiomyocytes (Hoerter and Vassort, 1982). At early stages of development, the fetal
heart grows largely through rapid proliferation of cardiomyocytes (Jonker et al., 2007a).
However, towards the end of gestation, cardiac cells become increasingly differentiated
and therefore lose the ability to propagate. Immature heart cells lose the ability to
proliferate during perinatal periods, with subsequent growth due primarily to enlargement
of existing cardiac cells. In comparison, adult mammalian heart cells maintain a
permanently differentiated disposition with little or no ability to self-reproduce (Rudolph,
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2000). The change in the proliferation capacity in cardiomyocytes corresponds to the
maturation of contractile machinery and the increase in population of poly-nucleated
cells. It is likely the highly ordered structure of mature cardiomyocytes, coupled with the
continuous contraction necessary for cardiac output and poly-nucleated disposition,
preclude self-propagation. In nature, there exists species capable of regenerating heart
cells at an adult stage. The adult newt and zebrafish are both capable of regenerating
substantial portions of heart tissue (Oberpriller, 1974; Poss et al., 2002). In particular, the
adult newt seems to possess the ability to dedifferentiate cardiac cells and proliferate to
replace lost or damaged tissue (Bettencourt-Dias et al., 2003). Among other important
factors, activation of p38 MAP kinase appears to play an important role in inhibiting
cardiomyocyte growth. The expression of p38 MAPK expression is inversely correlated
with cardiomyocyte proliferation, while inhibition of p38 isoforms promotes increased
expression of genes vital for self-propagation (Engel et al., 2005). These findings imply
that mammalian adult heart cells have the capacity to reproduce. Nonetheless, the factors
that give the immature heart cell, adult newt and zebrafish the ability to reproduce may
shed light that may promote the development of therapies that can assist in the recovery
of heart tissue following a coronary event.

Hemodynamic Stress
Functionally, the embryonic heart at an early stage sets itself apart from most
organs in that it is called upon to work almost from its inception. As the vascular system
forms, there is an increased stress placed on the fetal heart. However, the plastic nature
of the developing myocardium gives it the ability to adjust to hemodynamic load brought
upon it by an enlarging peripheral vascular system. An increase in afterload, or elevation
8

in pressure required to eject blood to systemic tissues, requires compensatory growth of
the myocardial wall. Laplace’s law explains the relationship between wall thickness and
increases in afterload. It states that increases in intraluminal pressure will produce
increased wall stress for a given radius. It is compensated by increased wall thickness or
decrease internal radius. This phenomenon is seen in individuals with pulmonary
hypertension that increases the intraventricular end diastolic pressure resulting in
thickening of the right heart wall. In fetal sheep, Barbera et al. (2000) demonstrated that
right ventricular wall thickness increases in response to pulmonary artery occlusion,
which is an increase in systolic pressure load. The findings from this study suggested
that the increase in heart size was primarily due to hyperplasia of cardiomyocytes,
although some growth could be attributed to hypertrophy. Indeed, arterial hypertension
in fetal sheep increases the weight of hearts, stimulates proliferation, size and
binucleation of cardiomyocytes resulting in increased growth and accelerated maturation
of the myocardium as a compensatory response to increased afterload (Jonker et al.,
2007b). Therefore, ventricular wall mass is influenced by the hemodynamic stress under
which it develops.

Hypoxia and the Developing Heart
Methods for Determining Hypoxia In Utero
Hypoxia in vivo is a challenging phenomenon to study; yet, several techniques are
used to either measure oxygen tension directly or indirectly in vivo. The surgical
implantation of O2 sensitive sensors is a method commonly used on larger animals, such
as pregnant sheep, to measure fetal pO2 (Kamitomo et al. 1994). Additionally, the unique
metabolic plasticity of the fetal heart allows it to rapidly increase glycolysis under
9

conditions of oxygen deprivation (Ascuitto and Ross-Ascuitto, 1996). The switch from
aerobic to anaerobic respiration corresponds to increases in glycolytic intermediates, such
as lactate, that have been used as an indicator of reduced mitochondrial oxidative activity
in response to oxygen insufficiency (Breuer et al. 1968). Beyond surgical implantation
and metabolism, Chapman (1979) was the first to suggest the use of nitroimadazole
compounds (e.g. EF5, pimonidazole) to study hypoxia. In low oxygen conditions,
nitroimadazole compounds are chemically reduced by nitroreductases, which permit
covalent binding to intracellular proteins to form adducts (Evans et al. 2007, 2008).
Nitroimadazole compounds have been used to study the effects of hypoxia in
embryogenesis and tumorgenesis (Wikenheiser et al. 2006; Koch and Evans, 2003).
Tissue hypoxia alters gene expression patterns. Hypoxia stabilizes HIF (1, 2 and
3), a family of transcription factors that play a central role in cellular adaptation to
insufficient oxygen. The discovery of HIF sheds new light on the role of hypoxia in fetal
heart maturation. HIF is comprised of a α and β subunit, of which the former is oxygensensitive and affects HIF stability, and the latter is oxygen-insensitive. HIF is widely
known to up-regulate numerous genes associated with external and internal cellular
adaptation to hypoxia (Iyer et al. 1998; Semenza, 1998; Ward, 2008). A classic example
of HIF associated gene transactivation is the induction of erythropoietin (EPO). Hypoxia
promotes HIF-induced up-regulation of EPO (Jiang et al. 1996). EPO stimulates
erythropoiesis, inhibits apoptosis, and mobilizes endothelial progenitors for vessel growth
by binding to EPO receptors (Arcasoy, 2008; Marzo et al. 2008). HIF and HIF dependent
gene expression have become important indicators of tissue hypoxia. Their use has
increased our understanding of the role of reduced oxygen in cardiogenesis from a
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standpoint of transcriptional changes. HIF regulation will be discussed in detail later in
the introduction.

Outflow Tract Remodeling
Recent studies in avian and mouse models suggest that hypoxia plays a critical
role in the formation and development of the heart. Many of these studies were centered
on the remodeling of the embryonic outflow track (OFT) and coronary vessel formation.
Embryonic OFT remodeling is necessary for the proper transition from single to dual
circulation in mammalian and avian hearts (Fisher, 2007). Apoptosis of OFT
cardiomyocytes is vital for proper remodeling of OFT (Watanabe et al. 2001; Barbosky et
al. 2006). Programmed cell death of OFT cardiomyocytes brings about the shortening
and rotation needed for the aorta to join the left ventricle and pulmonary vessels to
connect to the right ventricle. At the height of cardiomyocyte apoptosis in the OFT,
researchers have observed increases in EF5 (chemical marker of hypoxia) staining as well
as increased nuclear accumulation of HIF-1; suggesting hypoxia via HIF-1 may be
involved in OFT remodeling (Sugishita et al. 2004b; Barbosky et al. 2006). Druyan el al.
(2007) demonstrated in chick fetal hearts the up-regulation of hypoxia-regulated genes,
heme oxygenase, cardiac troponin T and hypoxia up-regulated protein 1 at specific
developmental periods (E7 and E19). Heme oxygenase facilitates the degradation of
heme and protects against oxidative stress. Cardiac troponin T is involved in calcium
handling and contractions of the heart, and hypoxia up-regulated protein 1 protects
against cell death during hypoxia. These finding suggests that as the heart develops under
hypoxic conditions, cellular defense pathways are employed in order to sustain normal
growth, while protecting against oxidative stress and apoptosis. Ironically,
11

cardiomyocytes exhibit increased oxidative stress as a result of hypoxia (Duranteau et al.
1998). Oxidative stress can cause cellular damage, which may lead to cell death. In
subsequent experiments, EF5 staining revealed differential levels of oxygen in fetal
hearts with areas of low oxygen correlating spatially and temporally with apoptosisinduced myocardial remodeling (Sugishita et al. 2004a & 2004b; Lee et al. 2001). These
findings were further substantiated by experiments that demonstrated intense EF5
staining and cell death of OFT cardiomyocytes that were attenuated by hyperoxia
resulting in OFT defects. Such defects included the abnormal formation of the right
ventricles, which clearly associated oxygen regulation with proper myocardial formation
(See Figure 1) (Barbosky et al. 2006). It appears the timing of the hypoxic insult is tightly
regulated for proper heart remodeling. Low oxygen was reported in chick at stages 25-32
and around day 13.5 of gestation in mice (Sugishita et al. 2004; Barbosky et al. 2006).
Interestingly, the timing and duration of hypoxia plays an important role in the
development of other tissues. In the first trimesters, placenta tissues develop under low
pO2 (<20mm Hg), which rises considerably in second trimester, (~60mm Hg) then
declines (~40mm Hg) by the third trimester (Rodesch et al. 1992; Jaunaiux et al. 2001;
Soothill et al. 1986). Accordingly, studies suggest the fluctuation in pO2 modulates
trophoblast differentiation and invasion, affording concomitant growth of the placenta
throughout gestation (Pringle et al. 2010). These findings indicate that hypoxia functions
in several tissues to signal changes that promote normal development.

Coronary Vessel Formation
In embryonic tissues, the formation of primary blood vessels from endothelial
precursors called angioblasts is known as vasculogenesis. During vasculogenesis,
12

angioblasts combine and form the primary capillary plexus, which serves as the
framework from which all subsequent vessel formation occurs. After the establishment
of the primary capillary plexus, subsequent budding and sprouting of new vessels from
preexisting ones is known as angiogenesis. Though proper vessel development and
maturation involves input from multiple signals, VEGF signaling plays a vital role
throughout vessel formation and growth. The binding of VEGF to receptor tyrosine
kinases (e.g. KDR/Fik-1, Fit-1 in endothelial cells) initiates the expression of genes
necessary for the recruitment, proliferation, and differentiation needed for vasculogenesis
and angiogenesis (Covassin et al. 2006; Nasevicius et al. 2000; Martyn and SchulteMerker, 2004; Weinstein and Lawson, 2002). For a more thorough review of VEGF
signaling, consider the following excellent reviews (Papetti and Herman, 2002; Josko et
al. 2006; Roskoski, 2008; Yia-Herttuala et al. 2007). In cardiogenesis, VEGF is essential
for vessel growth and the induction of VEGF correlated spatially with coronary vessel
patterning (Tomanek et al. 1998, 1999 & 2003). In addition, cardiomyocyte-restricted
knockout of Vegf impaired coronary vessel development, promoted myocardial
thinning, depressed basal contractile function, and caused significant dysfunction of betaadrenergic stimulation (Giordano et al. 2001). Also, mice deficient of receptor tyrosine
kinase showed abnormal heart development, primarily ventricular septal defects
(Takeuchi et al. 2000). These findings suggest that VEGF-mediated vessel formation
promotes adequate growth, remodeling and function of the myocardium.
Hypoxic stress increases vessel formation in fetal heart tissue, while hyperoxia
delays vessel growth (Yue and Tomanek, 1999). Studies have confirmed that hypoxia is a
major stimulus for vessel growth in fetal development and tumorgenesis (Yue and
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Tomanek, 1999; Lainakis and Bamias, 2008; Hu et al. 2003). Hypoxia is known to
stabilize HIF-1& 2, which preferentially up-regulates VEGF and its receptor (Hu et al.
2003; Forsythe et al. 1996). However, studies conducted by Kotch et al. (1999) showed
that VEGF mRNA increased modestly (compared to controls in HIF-1α null mice),
suggesting additional factors may regulate VEGF induction in fetal heart tissue. For
example, induction of VEGF in the absences of HIF-1α may be explained by the presence
of HIF-2α (which is known to up-regulate VEGF and VEGF receptors), or by the
increased stability of VEGF mRNA in hypoxic conditions. Furthermore, other growth
factors such as platelet-derived growth factor (PDGF) have been shown to induce VEGF
expression (Edelberg et al. 1998), suggesting VEGF can be induced independent of HIF1 activity. However, other findings have linked hypoxic stimulus through HIF-1
stabilization with significant induction of VEGF and VEGF receptor in cardiogenesis
(Lee et al. 2001; Liu and Fisher, 2008). The central role of hypoxia-dependent genes
during cardiogenesis suggests that oxygen regulation at the molecular level plays a major
role in fetal heart formation.

The Role of HIF in Cardiac Formation and Maturation
Oxygen Regulation
The molecular signals underpinning hypoxia’s role in cardiac formation and
development involves numerous genes. By far, the HIF family of genes is the most
studied in cardiac development. HIF is a heterodimeric transcription factor that plays a
pivotal role in cellular sensing and response to low oxygen tension. HIF belongs to the
basic helix-loop-helix (bHLH)/Per-ARNT-Sim (PAS) domain family of transcription
factors and is composed of an oxygen-sensitive α subunit and constitutively expressed β
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subunit (Semenza, 1998; Jiang et al. 1996a; Ward, 2008). It is known to regulate
numerous functions during hypoxia such as energy metabolism, erythropoiesis, cell
survival and death, vascularization, angiogenesis, and differentiation (Semenza et al.
1999; Adelman et al. 2000; Cowden et al. 2005; Covello et al. 2006; Galanis et al. 2008).
Although HIF stability and activity is influence by a wide range of physiological factors
(i.e. Insulin like Growth Factor 1 & 2), the effect of oxygen is most understood. Oxygen
tension regulates HIF-1 expression via prolyl hydroxylase (PHDs) activity. Under
normoxic conditions, the HIF-1α subunit is recognized and hydoxylated at proline
residues 402 and 564 by PHDs. Hydroxylation allows recruitment and binding of the von
Hippel-Lindau protein, an E3 ubiquitin protein ligase, which primes HIF-1α for
subsequent proteasome degradation. In addition, the transcriptional activity of HIF-1 is
also regulated by hydroxylation. Hydroxylation of arginine 803 by Factor inhibiting
HIF-1 (FIH) prevents the association of HIF-1 and CREB-binding protein (CBP)/p300,
precluding the transactivation of HIF-1 dependent genes (Mahon et al. 2001). When
cellular oxygen levels fall, the activity of PHDs and FIH are reduced, allowing stability
of the HIF-1α subunit. Interestingly, HIF-1 stability is inversely proportional to oxygen
concentration within the cell (Jiang et al. 1996b). Stable HIF-1α subunit translocates into
the nucleus where it dimerizes with HIF-1β and transactivates HIF-1 genes that possess
hypoxic response elements (HRE) (short sequences of DNA that include 5’-CGTGC/T3’).

HIF and the Developing Heart
Both HIF-1αβ & 2 αβ are expressed in the cardiac tissue (Wiesener et al. 2003;
Stroka et al. 2001). Little is known about the role of HIF-2 in heart formation and
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development, although HIF-2 knockout impairs vascular development as well as altered
cardiac rhythm due to the deregulation of catecholamine release (Peng et al. 2000).
Though it is not fully understood how HIF-1 dependent mechanisms coordinate in
cardiogenesis, it is known that HIF-1 expression is vital for proper myocardial
remodeling and coronary vessel formation. Elevated HIF-1 expression is found in fetal
hearts exposed to hypoxia (Sugishita et al. 2004; Bae et al. 2003). HIF-1 was also found
in the nuclei of OFT cardiomyocytes undergoing apoptosis as well as those that are not
(Sugishita et al. 2004). This implies HIF-1 activity is involved in orchestrating OFT
cardiomyocyte fate. The importance of hypoxic-dependent signaling in myocardial
development is further supported by studies using mice deficient in HIF-1. Global
knockout of HIF-1α resulted in arrested development by day E9 and embryonic lethality
by day E11 with significant cardiovascular irregularities including cardiac bifida,
abnormal cardiac looping, abnormal remodeling of the aortic outflow tract and cephalic
blood vessels, and mesenchymal cell death (Compernollo et al. 2003; Iyer et al. 1998).
When HIF-1α null mice were placed in hyperoxia, partial recovery of the embryos was
observed, suggesting that adaptation to hypoxic conditions requires HIF-1 signaling in
the developing heart (Compernollo et al. 2003). HIF-1 is known to up-regulate, either
directly, through binding to HRE sites, or indirectly, by influencing other transcription
factors that promote prosurvival and apoptotic genes. In the fetal heart, HIF-dependent
activation of VEGF, stromal cell-derived factor-1 and EPO receptor expression promote
the vessel formation (Ladoux and Frelin, 1997; Tilmanns et al. 2008; Maloyan et al.
2005). In addition, survival signals in the myocardium are augmented by HIF-dependent
direct activation of glycolytic genes such as Glucose transporter 1 (Glut1), aldolase A,
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enolase 1 (EN01), lactate dehydrogcnasc A, and phosphoglyceratc kinase 1(PGK1),
which facilitate the shift from aerobic to anaerobic respiration (Wenger and Gassmann,
1997; Gordan and Simon, 2007). Paradoxically, HIF-1 has been shown to up-regulate
proapoptic genes BNIP3 and Bax in cardiomyocytes (Graham et al. 2004). This dual role
of HIF is also seen in cerebral ischemia models where HIF-1 up-regulates prosurvival
(EPO, GLUT1, VEGF) and death genes (BNIP3, caspase 3, stabilization of p53)
depending on the extent and duration of the ischemic insult (Chen et al. 2009). It is likely
that complex mechanisms contribute to the duality of HIF-1 signaling in cardiogenesis.
Presumably the ability of HIF-1 to bind HRE sites and thus influence gene activity
changes depending on the timing and duration of hypoxic insult. This twin nature of HIF
may influence HIF-dependent cardiomyocyte survival or death, and possibly play a role
in long-term programming of fetal cardiomyocytes during chronic hypoxia.

Fetal Hypoxia and Abnormal Heart Development
Though fetal hearts show remarkable ability to survive and function under low
oxygen, chronically pathophysiological hypoxia is associated with numerous
complications that have both short and long-term effects. Some of the most striking data
illustrating the effects of hypoxia on fetal development originate from high altitude
studies. About 140 million people live in high altitude environment worldwide, of which
some 400,000 live in the United States (Moore et al. 2001). High altitude is considered to
be elevations above 2500 meters (8000ft) (Moore et al. 2001). Pregnancies at higher
elevations may result in significantly depressed maternal arterial pO2 and changes in
placental growth when compared to the sea level (Zamudio, 2003). Epidemiological
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studies have indicated that high altitude pregnancies increase the risk of intrauterine
growth restriction (IUGR) and low birth weight (Jensen and Moore, 1997; Moore et al.
2001; Moore, 2003). These factors are known to cause premature birth, infant mortality,
and an increased risk of developing cardiovascular related diseases (Barker et al. 1989;
Barker, 1994; Barker, 1997; Zhang, 2005). Other factors that may contribute to hypoxia
in utero include pre-existing maternal illness, pre-eclampsia, cord compression, smoking,
pollution, hemoglobinopathy, and aberrant placenta development. Lowered maternal
arterial pO2 or incomplete delivery of oxygen to fetal tissues induces hypoxemia and
sustained tissue hypoxia in utero, resulting in significant changes in fetal development
(Blackburn, 2007; Lueder et al. 1995).
The developing heart, more than any other organ, is susceptible to hypoxic stress
due to its enhanced metabolic demand. Numerous studies, primarily in animals, have
shown that hypoxia causes incomplete development of the heart. One of the earliest
studies demonstrating the adverse effects of simulated high altitude on pregnant rats
found that hypoxia caused ventricle septal defects in rat offspring (Clemmer, 1966). More
recent studies have found that insufficient oxygen in utero produces myocardial thinning,
ventricle dilation, and epicardium detachment. It also slows fetal heart maturation in both
chicken and mouse (Ream et al. 2008; Sharma et al. 2006). Other studies demonstrated
cardiomyocyte hypertrophy and myocardial hypoplasia in fetal hearts subjected to
chronic hypoxia (Val’kovich et al. 1986; Martin et al. 1998; Bae et al. 2003; Ream et al.
2008). It is likely that the increase in size of cardiomyocyte is compensatory for reduced
proliferation of myocyte. Interestingly, studies have found that prenatal hypoxia increases
the heart to body mass ratio (Martin et al. 1998; Xiao et al. 2000; Bae et al. 2003),
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suggesting either reduced growth of nonessential organs or heart enlargement. The
reduction in cardiomyocyte number is likely influenced by either increased program cell
death and/or reduced cellular proliferation during critical periods of development.
Hypoxia-mediated increase in apoptosis is supported by studies that indicate that prenatal
hypoxia increased death signaling via elevated caspase 3 activity and Fas mRNA, and
also suppressed survival pathways via depressed Bcl-2 and Hsp70 expression in fetal
hearts (Bae et al. 2003). Conversely, the reduction in cardiomyocyte may be attributed to
premature exit of cardiomyocytes from the cell cycle. Bae et al. (2003) reported that
prenatal hypoxia increased the percentage and size of binucleated cardiomyocytes in fetal
rat hearts. Binucleated cardiomyocytes are terminally differentiated cells that are no
longer capable of division. Taken together, prolonged insufficient oxygen alters fetal
heart growth resulting in abnormalities in heart structure. These abnormalities likely
involve sustained reduction in cardiomyocyte proliferation and increased apoptosis.
Intrauterine stress via hypoxia induces not only changes in fetal heart
morphology, but also in function. In humans, changes in fetal heart rate have long been
observed in fetuses in response to intrauterine stress (Thornburg, 1991). Animal studies
have also confirmed the dysfunction of the myocardium in response to hypoxia. Sedmera
et al. (2002) demonstrated that the rate of recovery from anoxia/reoxygenation declines
from the loop tubular heart to the septated trabeculated heart, suggesting oxygen
dependence increases with the development. In a study examining the significance of
catecholamines in development, researchers reported hypoxia decreased the heart rate of
fetal mice by 35-40% in culture and by 20% in utero when compared to wild-type hearts
(Portbury et al. 2003). High altitude Sheep models also present with altered cardiac
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function in response to prenatal hypoxia as demonstrated by decreased cardiac output and
lowered contractility studies (Kamitomo et al. 1994 & 2002; Gilbert, 1998; Browne et al.
1997). Possible explanations for the depressed cardiac function relate to altered calcium
homeostasis and reduced ATP availability due to decreased Mg2+-activated myofibrillar
ATPase activity (Browne et al. 1997; Kamitomo et al. 2002; Onishi et al. 2004). In avian
models, poor cardiac performance was observed as demonstrated by decreased maximum
ventricular +dP/dt and peak pressure, increased ventricular end-systolic volume, elevated
after-load, and decreased left ventricular ejection fractions (Sharma et al. 2006; Tintu,
2009). Whether hypoxia directly mediates or indirectly facilitates these changes is not
clear. Studies suggest that cardiac defects such as cardiac bifida and looping defects may
be mediated via A1 adenosine receptor signaling in chicken hearts (Ghatpande et al.
2008). Sarre et al. (2006) demonstrated in an in vitro model arrhythmias in 4-day-old
isolated embryonic hearts subjected to anoxia/reoxygenation. Graf et al. (2006) observed
an increased rate of contractions and decreased sensitivity to norepinephrine of cultured
rat cardiomyocytes exposed to hypobaric hypoxia during organogenesis. In utero stress
may cause an increase in circulating stress hormones, which may explain reduced cardiac
performance. In addition, structural changes in the myocardium may contribute to
depressed cardiac function. It should be noted that many hypoxic models involve
maternal exposure to reduced room oxygen. More studies demonstrating the direct effect
of hypoxia on fetal hearts are warranted. Taken together, prolong exposure to hypoxia in
utero alters heart structure and function and these changes may persist into adulthood.
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Hypoxia and Intrauterine Programming of the Heart
Many studies have correlated an adverse intrauterine environment with an
increase predisposition for developing cardiovascular-related diseases in adulthood. Most
notably, epidemiological studies by Barker and colleagues (Barker, 1989; Barker and
Osmond 1986) were the first to correlate undernutrition and low birthweight with
increased incidence of coronary heart disease in adulthood. Hypoxia in utero is known to
cause depressed cardiac performance and cardiomyopathies that persist into adulthood
(Tintu et al. 2009). It is less clear, however, the extent to which hypoxia mediates
programming of genes that alter structure, function and survival that are not apparent
until later in life.
Recently, researchers have used animal models to elucidate the role of hypoxia in
intrauterine programming. Li and colleagues demonstrated that 6-month-old male rat
hearts exposed to prenatal hypoxia responded less favorably than control animals when
subjected to simulated ischemia and reperfusion (I/R) injury (Li et al. 2003). The
hypoxic animals exhibited a persistent decrease in postischemic recovery, an increase in
myocardial infarction (MI), and fewer but larger cardiomyocytes. In addition, the hearts
of these animals had elevated caspase 3 activity and decreased levels of Hsp70 and eNOS
when compared to control animals. While both Hsp70 and eNOS play important roles in
cardioprotection against I/R injury, caspase 3 belongs to a family of proteases that
perform critical cellular functions to facilitate programmed cell death (Nicholson et al.
1995; Okamura et al. 2000; Snoekx et al. 2001; Sharp et al. 2002). Xu and colleagues
also observed lower levels of metalloproteinase-2 in 4-month-old rats (Xu et al. 2006).
Moreover, prenatal hypoxia abolishes the protective affects afforded by heat stress
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against I/R injury and significantly reduces HSP70 and PKC content in the left
ventricles (Li et al. 2004). Furthermore, Xue and colleagues showed that prenatal hypoxia
caused a decrease in I/R recovery in 3-month-old male, but not female, rat offspring (Xue
and Zhang, 2009). When normoxic offspring were exposed to simulated I/R in the
presence of PKC translocation inhibitor peptide, those animals also displayed reduced
I/R recovery; suggesting that programming of decreased PKC gene expression is key to
the observed increase vulnerability to I/R injury in males (Xue and Zhang, 2009). This
finding is supported by studies involving PKC over-expression, PKC null animals, and
PKC activating peptide, which confirm the pivotal role of PKC in I/R preconditioning
and myocardial protection (Saurin et al., 2002; Ping et al. 2002; Inagaki et al., 2005 &
2006).
Conversely, Netuka et al. (2006) reported no difference in MI in prenatally
hypoxic rats of either sex, but noted that normoxic females had less MI than normoxic
males when exposed to I/R. They also noted that prenatal hypoxia protected against
ischemic-induced arrhythmias of female rats, but was deleterious in male rats. The
disparate results reported by Li (2003), Xu (2006) & Xue (2009) and Netuka’s (2006)
studies might be explained by differences in strain, age, and experimental models.
Whereas the Xue (2009), Xu (2006) and Li (2003) studies used 3, 4 & 6-month-old
Sprawley Dawley rats respectively exposed to hypoxia only in utero, Netuka (2006) used
3-month-old Wistar rats exposed to intermittent hypobaric hypoxia in utero and 10 days
postgestation. In addition, Li et al. (2003) used simulated I/R insult with hearts removed
from the animal, while Netuka et al. (2006) performed open chest I/R insult. These
reasons may explain the differing results; nonetheless, both groups drew similar
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conclusions in that prenatal hypoxia causes programming of the fetal heart. It is also clear
that prenatal hypoxia has sex dependent effects, as demonstrated by poor recovery of
male rats, which likely involves altered programming of cardioprotective genes, namely
PKC.
The long-term effect of hypoxia in utero is not restricted to the cardiovascular
system but also produces programming affects in other tissues. Pregnant sheep exposed
to chronic high altitude conditions had significant reduction in kidney to body weight
size, larger Bowman’s capsule in nephrons and alterations in angiotensin I and II
expression (Mao et al. 2009). Long-term hypoxia alters the expression of CYP17 and
CYP11A1 in fetal sheep adrenal glands (Myers et al. 2005). CYP17 and CYP11A1 are
two key enzymes involved in steroidogenesis, suggesting that high altitude exerts stress
on animals such that elevated levels of stress hormone may be measured in fetal tissues.
Whether this expression pattern is maintained into adult stages is not known.
Furthermore, the direct effects of hypoxia are not clear. The maternal hypoxic model is
capable of significantly lowering fetal oxygen status. However, maternal hypoxia elicits
other systemic effects that may reflect the observed effects. For example, maternal
hypoxia increases circulating glucocortoids that may cause abnormal development of the
fetus (Levitt et al. 1996). Identifying the direct effects of hypoxia on fetal heart
development is critical to understanding the underlying mechanisms involved in hypoxiainduced programming of fetal hearts.
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Hypoxia and Oxidative Stress
The majority of ATP synthesizes occurs in the mitochondria through oxidative
phosphorylation. Oxidative phosphorylation utilizes proton concentration differences
across the inner membrane of the mitochondria to create an electrochemical gradient. The
electrochemical gradient is important in several functions including the transport of
metabolites across the membrane, the import of proteins from the cytosol and the
synthesis of ATP by ATP synthase. During this process, the majority of oxygen is
reduced to water. However, between 1-4% of oxygen is only partially reduced to
superoxide (O2-). O2- belongs to a family of compounds called Reactive Oxygen
Species (ROS). ROS can oxidize and damage nucleic acids, lipids, and proteins resulting
in significant cellular damage. Typically, superoxide is eliminated by endogenous
antioxidant defense systems. For example, Mitochondrial Superoxide Dismutase
(mtSOD) converts superoxide to hydrogen peroxide (H2O2). H2O2 is further broken down
into H2O and O2 by glutathione peroxidase or by catalases found in peroxisomes. In the
presence of reduce metals, H2O2 is converted to the highly reactive hydroxyl ion (OH).
A significant endogenous antioxidant is the reduced form of glutathione. Glutathione
reductase and NADP regenerate Glutathione. When antioxidant defense systems are
unable to restore cellular redox balance, Glutathione levels fall promoting a state of
oxidative stress. In cardiomyogenesis, oxidative stress plays an important role in
signaling events that regulate cardiomyocyte differentiation (Sauer and Wartenberg,
2005).
Hypoxia is a unique phenomenon in that it paradoxically increases intracellular
ROS (Chandel et al., 1998; Mansfield 2005; Liu et al., 2008). Interestingly, Chandel et
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al., (1998) reported hypoxia increases ROS; influences hypoxic dependent gene
expression and that the primary source of hypoxia-induced ROS is the mitochondria.
Furthermore, mitochondrial complex III was identified as the major site of mtROS
productions (Guzy & Schumacker, 2006). Hypoxia increases probability of free radicals
interacting with oxygen to produce superoxide along the electron transport chain.
Interestingly, studies have suggested that hypoxia-derived ROS via mitochondrial
complex III initiates the events necessary for HIF-1 stabilization (Chandel et al., 2000).
The change in intracellular redox state reduces the levels of Fe2+, a necessary cofactor
for prolyl hydroxylases hydroxylation of HIF-1. Reduced prolyl hydroxylases activity
allows nuclear accumulation of HIF-1. While this theory is most commonly accepted, a
recent study contends that oxygen availability instead of ROS production is the main
stimulus altering prolyl hydroxylase activity and therefore HIF-1α stabilization (Chua et
al., 2010). ROS is known to alter gene expression patterns. Studies have shown
moderate hypoxia induces intracellular ROS production that initiates the Integrated Stress
Response (ISR), which involves PERK activation, eIF2 phosphorylation and ATF4mediated stress gene induction (Liu et al., 2008). These events alter global protein and
mRNA synthesis, which is a likely response to reduce energy production. These findings
suggest oxidative stress generated by the mitochondria as a result of hypoxia may
increase HIF-1 nuclear accumulation as well as influence gene expression.
ROS causes extensive DNA damage that can lead to genomic mutations and
tumor formation, but researches have sought to determine the link between oxidative
stress and epigenetic modifications. In one elegant study, researchers demonstrated
oxidative stress decreased E-cadherin expression in hepatocellular carcinoma cells (Lim
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et al., 2008). Reduced E-cadherin expression is associated with tissue-type transitions,
metastasis and poor outcomes in hepatocellular carcinoma (Endo et al., 2000). Lim et al.,
(2008) showed ROS increases Snail expression, which then recruits DNA
methyltransferase 1 (DNMT1) and histone deacetylase 1 (HDAC1). The interaction
between Snail and epigenetic modifiers caused increased methylation of E-caherin
promoter and reduced E-cadherin expression. It is therefore conceivable that hypoxiainduced ROS may mediate epigenetic changes in the promoters of cardioprotective genes,
resulting in long-term down regulation of cardioprotective genes in fetal cardiomyocytes.
(See figure 16).

PKCε and Cardioprotection
PKCε belongs to a group of phospholipid-dependent kinases. PKC isoforms share
common domains in the regulatory region such as pseudosubtrate domains that binds the
substrate recognition site while the kinase is inactive; C1a and C1b domains for
diacylglcerol, phosphatidylserine, and phorbol ester binding; and, C2 region for receptor
activated C kinase (RACK) interaction (Newton, 1995). PKC isoforms contain
significant homology within the kinase or catalytic domain. The kinase domain is the
region where ATP and substrate binding occurs. PKC isoforms are divided into three
groups based on their primary structure. Conventional isoforms (α, βI, βII, γ) are
responsive to diacylglcerol (DAG) and Ca2+. Novel isoforms (δ, ε, η, θ) are DAG
sensitive and Ca2+ insensitive. Atypical isoforms (ζ, ι/λ) are insensitive to both DAG and
Ca2+, and are responsive to lipid-derived molecules (Newton, 1995). Compounds that
mimic DAG binding to C1 domain such as tumor promoting phorbol ester can also
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activate PKCε. Moreover, lipid-derived molecules such as arachidonic acid can activate
PKCε. Interestingly, PKC isoforms must be primed through phosphorylation at three
sites termed; the activation loop, hydrophobic motif and turn motif; in order to fully
respond to allosteric regulators (Barnette, 2007). Phosphorylation is initiated either by 3phosphoinositide-dependent protein kinase-1 (PDK1) or through autophosphorylation
mechanisms. Once activated, PKC translocates to subcellular compartment via its
interaction with RACK proteins. PKC then influences a wide array of cellular functions
including muscle contraction, gene expression, differentiation, cell growth and ischemic
preconditioning (Bogoyevitch & Sugden, 1993; Newton, 1995).
PKCε is highly expressed in heart tissue and is activated during ischemic
preconditioning (IPC) (Bogoyevitch & Sugden, 1993; Gray et al., 1997). Knockout
studies indicate PKCε is not critical for development, but plays a critical role in ischemic
reperfusion preconditioning (Saurin et al., 2002). Studies using PKCε translocation
inhibitory peptide (PKCε-TIP) and PKCε activating peptide provide further evidence of
PKCε involvement in myocardial protection from ischemic reperfusion injury (Ping et al.,
2002; Inagaki et al., 2004; Xue et al., 2009). The mechanism whereby PKCε protects
hearts from ischemia reperfusion injury has not been fully explained. However, ischemia
reperfusion insult increases the levels of intracellular ROS, which is known to stimulate
PKCε activity. ROS may activate PKC causing its translocation to the mitochondria.
Studies have shown PKCε interacts with mitochondrial proteins that potentially may
mediate cytoprotection (Ardehali, 2006). Studies have shown PKCε enhances
phosphorylation of BAD proteins, causing its inactivation and attenuating its ability to
induce apoptosis (Bertolotto et al, 2000). In addition, phosphorylation of mitochondrial
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KATP by PKCε during ischemic stress causes the opening of mitoKATP allowing K+ into
the inner matrix and thus hyperpolarizing and stabilizing the mitochondria. (Takano et
al., 2003; Das et al., 2003; Hausenloy et al., 2003; Ardehali H, 2006; Jaburek et al., 2006;
Kabir et al., 2006).

Epigenetics: A Plausible Mechanism
The mechanisms underlying the changes in function and gene expression in fetal
hearts are not fully understood and are complex; however, epigenetic modifications are
likely present. Major epigenetic modifications include methylation of cytosine in CpG
dinucleotide, and post-translation modification of histone proteins (e.g. acetylation).
DNA methylation plays a critical role in gene silencing and has been implicated in
processes such as imprinting and embryogenesis (Hirst, 2009). Methylated Cytosines
recruit methyl binding proteins that act to restrict binding of transcription factors to
promoter regions. Methylation of CpG is normally conserved during somatic replication.
Modifications of histone proteins can either increase or reduce the association of DNA
with histones thereby regulating access of transcription machinery for selected genes.
These modifications are dynamic and are influenced by a range of factors including the
expression of cofactors, phase of cell cycle (i.e. G1, S, mitosis), and environmental
stimuli (Nafee, 2008). Major histone modification include acetylation of lysine residues
via histone acetyltransferases that are associated with transcription activity; deacetylation
of lysine residues via histone deacetylases that are commonly associated with
transcription repression; methylation of lysine 4 on histone H3 is generally associated
with transcriptional active promoters while multiple methylation of histone restricts
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transcription (Hirst, 2009). Further modifications include phosphorylation,
ubiquitousation, hydoxlation, and sumolation. Histone modification not only influences
transcription, but DNA replication, repair, and condensation.
Epigenetics plays an important role in embryonic development. In embryogenesis,
developmental changes involve a progressive specialization of gene expression patterns
that incorporate epigenetic mechanisms such as DNA methylation, chromatin
remodeling, and/or histone posttranslational modification (Wu and Sun, 2006). Aberrant
epigenetic silencing or enhancing of genes that influences cell cycle, death, and
metabolism is commonly found in tumoriogenesis (Mckenna and Roberts, 2009; Hirst
and Marra, 2009; Delcuve et al., 2009). Epigenetic modifications alter gene expression
pattern in the long-term. In a related model, studies have demonstrated that maternal
cocaine injections increases DNA methylation at Sp1 binding sites in PKC promoter in
fetal hearts (Zhang et al., 2009; Meyer et al., 2009B). Maternal cocaine injections during
gestation induce intrauterine stress that results in increased susceptibility to I/R injury and
abolition of protection afforded by preconditioning in the hearts of male offspring (Bae et
al, 2005; Meyer et al., 2009A). In addition, reduced PKC and phospho-PKC
expression was noted in the left ventricles of male offspring exposed to maternal cocaine,
suggesting altered programming of the PKC gene (Meyer et al., 2009A). Zhang et al.
(2009) showed that cocaine exposure in utero caused hypermethylation of CpG
dinucleotides of Sp1 binding sites for PKC gene in left ventricles of 3-month-old rats.
Supporting this discovery was the finding that Sp1 binding sites on the proximal
promoter played a significant role in PKC gene transcription (Zhang et al., 2009). Meyer
et al. (2009A) used DNA methylation inhibitors 5-aza-2-deoxycytine and procainamide,
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to block cocaine-mediated down-regulation of PKC. These findings clearly link
epigenetics via DNA methylation in utero with the increased susceptibility to coronary
heart disease later in life. The similarities between prenatal hypoxia and cocaine
exposure are striking, and it is possible that the underlying mechanisms for both are
concurrent. It is well known that cocaine acts as a potent vasoconstrictor, which may
alter blood flow to the uterus resulting in oxygen insufficiency in utero. Furthermore,
both hypoxia and cocaine cause an increase in oxidative stress. How prenatal hypoxia
predisposes fetal hearts to I/R injury, and whether the mechanisms mirrors that of
cocaine, are fascinating questions that remain to be elucidated.

HIF and Epigenetics
To date, little is known about HIF-1 in epigenetics and whether it plays a role in
long-term gene silencing in immature cardiomyocytes. Since HIF activity is central to
cellular adaptation to hypoxic stress, it is plausible HIF may play a role in hypoxiainduced fetal programming of cardiomyocytes. Hypoxia through HIF plays an important
role in influencing transcription of multiple genes in embryogenesis. Epigenetic
mechanisms play an important role in the process of both cases. An example of the
influence of hypoxia in embryogenesis is seen in stem cell differentiation. Studies have
demonstrated that normal placental development requires HIF-1 induction for proper
trophoblast differentiation (Adelman et al., 2000; Cowden et al., 2005; Maltepe et al.,
2005). One fascinating study demonstrated that HIF-2 preferentially up-regulated Oct-4
(Wiesener et al., 2003). Oct-4 plays an important role in maintaining a dedifferentiated
cell disposition in embryonic stem cells, primordial germ cells and embryonic epiblast
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(Scholer et al., 1990; Suzuki et al., 1990; Nichols et al., 1998). Furthermore, reports have
shown the involvement of HIF-1 in tumor formation and irregular gene expression
silencing via DNA methylation (Kondo et al., 2002; Gordan et al., 2008). HIF-1 has also
been shown to interact directly with epigenetic modulators. Studies done by Beyer (2008)
and Wellmann et al. (2008) identified a HRE site in the proximal promoter of the histone
demethylase Jumonji domain containing 1A and 2B (JMJD1A, JMJD2B). JMJD1A and
JMJD2b demethylate H3K9 residues of histones, which are usually associated with
reduced acetylation and gene repression [Beyer et al., 2008; Chen et al., 2006). In renal
cell carcinoma, von Hippel Lindau activity is lost leading to aberrant expression of HIF-1
& 2, as well as increased expression and activity of histone demethylases JMJD1A and
JMJD2b (Kondo et al., 2002; Gordan et al., 2008; Krieg et al., 2000). In addition, studies
suggest that HIF-1 interacts directly with histone deacetylases 7 (HDAC7) (Maltepe et
al., 2005; Granger et al., 2008). The interaction seems to highlight HDAC7 ability to
enhance HIF activity by forming a complex with HIF and p300 and influencing gene
transcription. Histone deacetylases remove acetyl groups from histone residues, causing
structural changes that preclude the binding of transcription factors and RNA polymerase
II to gene targets. HIF-1 is known to influence cellular adaptation in response to acute
and chronic hypoxia; yet HIF-1 may also mediate long-term changes in gene expression
through direct modulation of epigenetic effectors.
Recently, studies have linked c-myc activity with HIF-1 and HIF-2. C-myc is a
proto-oncogene involved in cell proliferation and enhancement of cellular metabolism.
There is evidence that c-myc can modulate epigenetic mechanisms. Work done by He et
al. (2009) demonstrated a link between overexpression of c-myc and hypermethylation of
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CpG sites in the tumor suppressor gene’s retinoic acid receptor beta (RARbeta) and
PDLIM4 in a prostate cancer cell line. Brenner et al, (2005) found that c-myc is able to
direct DNA methyltransferase 3a (DNMT3a) to the p21Cip1 promoter through direct
binding with DNMT3a and Miz-1, identifying a potential mechanism for epigenetic
silencing in cancer. In cancer cell models, HIF-1 actively competes with c-myc causing
inhibition of gene targets, while HIF-2 promotes c-myc activity (Gordan et al., 2008;
Koshiji et al., 2004). These findings suggest HIF may also indirectly influence epigenetic
patterns through interaction with c-myc or other transcription factors. Undoubtedly, HIF1 plays an important role in normal fetal heart development, and may also play a key role
in fetal programming of the myocardium through modulation of epigenetic effectors.

Central Hypothesis
Our hypothesis is that hypoxia directly affects PKC expression in fetal hearts
through epigenetic modifications of the PKC promoter; and, hypoxia-induced HIF-1
stabilization and/or oxidative stress play a role in this process.

Significance
Increasing evidence suggests programming of protective genes in utero can
predispose offspring to developing coronary disease later in life. Particularly, PKC
expression is known to play a vital role in cardioprotection against ischemia reperfusion
injury; however prenatal hypoxia reduces PKC expression in adult hearts increasing the
susceptibility to I/R injury. Although hypoxia is known to cause certain
cardiomyopathies, little is known about the mechanism through which hypoxia mediates

32

programming of cardioprotective genes and whether it involves epigenetics. Since
hypoxic stress is a common insult during development and very little is known about the
role of epigenetics in hypoxia-induced down-regulation of cardioprotective genes, we
expect findings from our study to reveal a novel role of hypoxia and hypoxia-induced
gene expression in fetal programming of cardiomyocytes. We further anticipate our
findings to have relevance in areas beyond cardiogenesis; including embryogenesis and
tumorigenesis, where normal and aberrant gene programming as a result of epigenetic
modifications are common. Our findings will provide a greater understanding of how
adaptations in response to intrauterine stress, namely hypoxia, can influence cellular
responses to stress later in life.
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Abstract
Rationale: Epidemiological studies demonstrate a clear association of adverse
intrauterine environment with an increased risk of ischemic heart disease in adulthood.
Hypoxia is a common stress to the fetus, and results in decreased protein kinase C epsilon
(PKCε) expression in the heart and increased cardiac vulnerability to ischemia and
reperfusion injury in adult offspring in rats.
Objectives: The present study tested the hypothesis that fetal hypoxia-induced
methylation of CpG dinucleotides at the PKC promoter is repressive and contributes to
PKC gene repression in the heart of adult offspring.
Methods and Results: Hypoxic treatment of pregnant rats from day 15 to 21 of
gestation resulted in significant decreases in PKCε protein and mRNA in fetal hearts.
Similar results were obtained in ex vivo hypoxic treatment of isolated fetal hearts and rat
embryonic ventricular myocyte cell line H9c2. Increased methylation of PKCε promoter
at SP1 binding sites, -346 and -268, were demonstrated in both fetal hearts of maternal
hypoxia and H9c2 cells treated with 1% O2 for 24 h. Whereas hypoxia had no significant
effect on the binding affinity of SP1 to the unmethylated sites in H9c2 cells, hearts of
fetuses and adult offspring, methylation of both SP1 sites reduced SP1 binding. The
addition of 5-aza-2’-deoxycytidine blocked the hypoxia-induced increase in methylation
of both SP1 binding sites and restored PKCε mRNA and protein to the control levels. In
hearts of both fetuses and adult offspring, hypoxia-induced methylation of SP1 sites was
significantly greater in males than in females, and decreased PKC mRNA was seen only
in males. In fetal hearts, there was significantly higher abundance of estrogen receptor 
(ER) and  (ER) isoforms in females than in males. Both ER and ER interacted
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with the SP1 binding sites in the fetal heart, which may explain the gender differences in
SP1 methylation in the fetal heart. Additionally, selective activation of PKC restored the
hypoxia-induced cardiac vulnerability to ischemic injury in offspring.
Conclusion: The findings demonstrate a direct effect of hypoxia on epigenetic
modification of DNA methylation and programming of cardiac PKCε gene repression in
a sex-dependent manner, linking fetal hypoxia and pathophysiological consequences in
the hearts of adult offspring.

Keywords: Fetal heart, PKCε, hypoxia, epigenetics, DNA methylation

Introduction
Heart disease is the leading cause of death in the United States. In addition to
other risk factors, recent epidemiological and animal studies have shown a clear
association of adverse intrauterine environment with an increased risk of hypertension
and ischemic heart disease in adulthood.1-4 Hypoxia is a common form of intrauterine
stress, and the fetus may experience prolonged hypoxic stress under a variety of
conditions, including pregnancy at high altitude, pregnancy with anemia, placental
insufficiency, cord compression, preeclampsia, heart, lung and kidney disease, or with
hemoglobinopathy. Animal studies suggest a possible link between fetal hypoxia and
increased risk of cardiovascular disease in offspring.5-13 Studies in rats have demonstrated
that maternal hypoxia results in an increase in cardiac vulnerability to ischemia and
reperfusion injury in male offspring.10,14,15 In addition, it has been demonstrated that
down-regulation of protein kinase C epsilon (PKC) protein expression in the hearts of
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adult offspring is a mechanism for the increased heart susceptibility to ischemia and
reperfusion injury in the animals exposed to hypoxia before birth.14
Among other mechanisms, PKC plays a pivotal role of cardioprotection in heart
ischemia and reperfusion injury.16-18 The study in a PKC knock-out mouse model has
demonstrated that PKC expression is not required for cardiac function under normal
physiological conditions, but PKC activation is necessary for acute cardioprotection
during cardiac ischemia and reperfusion.19 The finding that fetal hypoxia resulted in a
decrease in PKC protein expression in the heart of adult offspring10,14 suggests that an
epigenetic mechanism may explain PKC gene repression in the heart. Epigenetic
mechanisms are essential for development and differentiation, and allow an organism to
respond to the environment through changes in gene expression patterns.20-22 DNA
methylation is a chief mechanism for epigenetic modification of gene expression patterns,
and occurs at cytosines in the CpG dinucleotide sequence.23 Methylation in promoter
regions is generally associated with repression of transcription, leading to a long-term
shutdown of the associated gene. Methylation of CpG islands in gene promoter regions
alters chromatin structure and transcription. Similarly, methylation of CpG dinucleotides
within transcription factor binding sites generally represses transcription.20,24,25 The
present study tested the hypothesis that fetal hypoxia-induced methylation of CpG
dinucleotides at the PKC promoter contributes to PKC gene repression in the heart of
adult offspring. Herein, we present evidence that hypoxia has a direct effect on PKC
expression in the fetal heart, and demonstrate in a cell model that hypoxia causes an
increase in methylation of CpG dinucleotides at the proximal promoter region of PKC
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gene, resulting in decreased binding of sequence-specific transcription factors to the
promoter and reduced PKC gene expression.

Methods
An expanded Methods section is available in the data supplement.

Experimental Animals
Pregnant rats were randomly divided into two groups: 1) normoxic control; and 2)
hypoxic treatment of 10.5% O2 from day 15 to 21 of gestation.14 Hearts were isolated
from near-term (21 d) fetuses and 3 months old offspring. To study the direct effect of
hypoxia on the fetal heart, hearts were isolated from day 17 fetal rats and cultured at 37
C in 95% air/5% CO2 and 1% O2 for 48 h, as reported previously.24

Cell Culture
H9c2 cells were grown and sub-cultured and experiments were performed at 7080% confluent. For hypoxic studies, cells were treated with 1%, 3%, or 10.5% O2,
respectively, for 24 h.

Western Blot Analysis
Protein abundance of PKC, SP1, alpha (ER) and beta (ER) subtypes of
estrogen receptors in H9c2 cells and hearts of fetuses and adult offspring were measured
with Western blot analysis, and were normalized to beta2-microglobulin (B2M), as
described previously.25, 26
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Real-Time RT-PCR
PKCε mRNA abundance in H9c2 cells and hearts of fetuses and adult offspring
was determined by real-time RT-PCR and was normalized to B2M.25, 26

Quantitative Methylation-Specific PCR
DNA collected from H9c2 cells and hearts of fetuses and adult offspring was
treated with sodium bisulfite at 55 C for 16 h. Bisulfite-treated DNA was used as a
template for real-time fluorogenic methylation-specific PCR (MSP) using primers created
to amplify promoter binding sites containing possible methylation sites based on our
previous sequencing of rat PKCε promoter.25

Electrophoretic Mobility Shift Assay (EMSA)
Nuclear extracts were collected from H9c2 cells and hearts of fetuses and adult
offspring. EMSA was performed using the oligonucleotide probes with either CpG or
m

CpG in the two SP1 binding sites (− 346 and − 268) at rat PKCε promoter region, as

described previously.25

Chromatin Immunoprecipitation (ChIP)
Chromatin extracts were prepared from H9c2 cells and fetal hearts. ChIP assays
were performed for the two SP1 binding sites at the PKCε promoter in DNA sequences
pulled-down by SP1, ER, and ER antibodies.25
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Hearts Subjected to Ischemia and Reperfusion
Isolated hearts from 3 months old male offspring were subjected to 20 minutes of
global ischemia followed by 30 minutes of reperfusion in the absence or presence of a
PKC activator peptide -RACK (0.5 M, KAE-1, KAI Pharmaceuticals) in a
Langendorff preparation, as previously described.14, 27 Post-ischemic recovery of left
ventricular function and lactate dehydrogenase (LDH) release were determined.14

Statistical Analysis
Data are expressed as mean ± SEM. Statistical significance (P < 0.05) was
determined by analysis of variance (ANOVA) followed by Neuman-Keuls post hoc
testing or Student's t test, where appropriate.

Results
Effect of Hypoxia on PKC Protein and mRNA in Fetal
Cardiomyocytes
Maternal hypoxia resulted in significant decreases in both protein and mRNA
abundance of PKC in fetal rat hearts (Figure 2A). Similar findings were obtained in
isolated fetal hearts treated ex vivo with 1% O2 (Figure 2A), demonstrating a direct effect
of hypoxia on PKC expression in the heart. Further study demonstrated in rat embryonic
ventricular myocyte cell line H9c2 that 1% O2, but not 3% or 10.5% O2, significantly
decreased PKC mRNA and protein levels as compared to 21% O2 (Figure 2B).
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Methylation of SP1 Binding Sites at the PKC Promoter
Eight putative transcription binding sites containing CpG dinucleotides at rat
PKC promoter were previously identified.25 Treatment of H9c2 cells with 1% O2 for 24
h resulted in a significant increase in methylation of SP1 binding sites at -346 and -268,
but decreased methylation of MTF1 binding site at -168, as compared to 21% O2 control
(Figure 3). Hypoxia did not change significantly the methylation status of Stra13,
PPARG, E2F, Egr1, and MTF1 at -603. Consistent with the findings in H9c2 cells,
maternal hypoxic treatment revealed a similar pattern of increased methylation of the two
SP1 binding sites, -346 and -268, at the PKCε promoter in the fetal hearts (Figure 3). In
addition, in vivo hypoxia resulted in an increase in methylation of the putative Egr1
binding site in the fetal heart (Figure 3).

Methylation Inhibits SP1 Binding
H9c2 cells were used to further determine the role of methylation in PKCε downregulation. Given the previous finding that deletions of the regions containing the
putative Egr1 site and MTF1 site at -168 had no significant effects on the PKCε promoter
activity,25 our further investigation focused on the two SP1 binding sites. SP1 binding
and the functional significance of the SP1 binding sites in the regulation of PKCε gene
activity was demonstrated previously.25 To determine if methylation of the SP1 sites
inhibits SP1 binding from nuclear extracts of H9c2 cells, EMSA was performed with
methylated and unmethylated oligonucleotide probes containing the SP1 sites at -346 and
-268. As shown in Figure 4, nuclear extracts from H9c2 cells bound and shifted the
double-stranded unmethylated SP1 oligonucleotides at both sites, but failed to cause a shift
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of the methylated SP1 oligonucleotides. This is consistent with the previous findings in fetal
rat hearts showing a loss of binding of the nuclear extracts to the methylated SP1
oligonucleotides.24

Effect of Hypoxia on SP1 Abundance and Binding Affinity
Western blots revealed that hypoxia caused a significant increase in nuclear SP1
abundance in H9c2 cells (Figure S1, available in the data supplement). In contrast, there
was no significant difference in SP1 abundance either in fetal hearts between control and
maternal hypoxic treatments, or in the hearts of both male and female offspring between
the control and prenatally hypoxic animals (Online Figure I). The binding affinity of SP1
to the unmethylated SP1 binding sites was determined in competition studies performed
in pooled nuclear extracts with the increasing ratio of unlabeled/labeled oligonucleotides
encompassing the SP1 sites at -346 and -268, respectively. Hypoxia had no significant
effect on the binding of nuclear extracts to either SP1 sites at -346 or -268 in H9c2 cells,
fetal hearts, or the hearts of both male and female offspring (Online Figure II).

Inhibition of DNA Methylation Restored PKC Expression
To determine the causal role of CpG dinucleotide methylation in the downregulation of PKC expression, we exposed H9c2 cells to 1% O2 in the absence or
presence of increasing concentrations of the DNA methylation inhibitor 5-aza-2’deoxycytodine. As shown in Figure 4, 5-aza-2’-deoxycytodine produced a concentrationdependent inhibition of hypoxia-induced decrease in PKC mRNA and 30 µM 5-aza-2’deoxycytodine restored the mRNA to normoxic levels. This was accompanied by

42

restoration of PKC protein (Figure 5). The inhibition of hypoxia-induced methylation of
the two SP1 binding sites by 5-aza-2’-deoxycytodine was demonstrated (Figure 6A). To
confirm that hypoxia-induced methylation alters SP1 binding to the PKCε promoter in the
context of intact chromatin, ChIP assays were performed using a SP1 antibody. Figure
6B shows that hypoxia caused significant decreases in the SP1 binding to both SP1 sites at 346 and -268, respectively, in H9c2 cells. However, in the presence of 5-aza-2deoxycytine, there were no significant differences in SP1 binding to the either sites
between hypoxic and normoxic samples (Figure 6B).

Sex Differences in Hypoxia-Induced Changes in Methylation and
PKC Expression
We further investigated the potential sex differences in hypoxia-induced
methylation of the SP1 binding sites and PKCε transcription. Maternal hypoxia caused a
minimal but significant increase in methylation at both SP1 binding sites in the hearts of
female fetuses, but induced significantly greater methylation in male fetal hearts (Figure
7A). PKCε mRNA was significantly decreased in the hearts of male but not female
fetuses (Figure 7B). The similar pattern of sex differences in the hypoxia-induced SP1
methylation and PKCε transcription was demonstrated in the hearts of male and female
offspring (Figure 7A, B). The sex difference observed in the fetal hearts was intriguing
given that male and female fetuses were likely exposed to the similar concentrations of
steroid hormones in utero. However, both ER and ER abundance was significantly
higher in the hearts of female, as compared with male fetuses (Figure 8A). Chromatin
immunoprecipitation assay demonstrated the PCR products of the two SP1 binding sites
in the DNA sequences pulled-down by both ER and ER antibodies in the fetal hearts
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(Figure 8B), suggesting an interaction between estrogen receptors and the SP1 binding
sites at the PKCε promoter.

PKC Activation Restored Hypoxia-Induced Cardiac Vulnerability to
Ischemic Injury
The cause-and-effect evidence of the functional importance of PKCε in hypoxiamediated, sex-dependent programming of increased heart vulnerability to ischemia and
reperfusion injury in adult male offspring has been previously demonstrated by selective
inhibition of PKCε with a PKCε translocation inhibitor peptide.14 To further demonstrate
that decreased PKC is an important factor in the hypoxia-induced increase in cardiac
ischemic susceptibility in male offspring, additional studies were performed in the hearts
in a Langendorff preparation using a selective PKC activator peptide -RACK
obtained from KAI Pharmaceuticals.16, 27-29 There were no significant differences in left
ventricle developed pressure (LVDP), heart rate (HR), dP/dtmax, dP/dtmin and coronary
flow rate at the baseline among all groups (Online Table I). In the absence of -RACK,
fetal hypoxia caused a significant decrease in post-ischemic recovery of LVDP and
increases in left ventricle end diastolic pressure (LVEDP) and lactate dehydrogenase
(LDH) release (Figure 8), as well as decreases in the recovery of dP/dtmax and dP/dtmin
(Figure S3), as previously reported.14 -RACK increased post-ischemic recovery of left
ventricular function as shown in the previous studies27, 29 and abolished the hypoxic
effects (Figure 9 and Online Figure III).
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Figure 2. Effect of hypoxia on PKC protein and mRNA. (A) Fetal hearts of maternal
hypoxia (MH) and isolated fetal hearts (IFH) treated with 1% (hypoxia) and 21% O2
(control) for 48 hours. (B) H9c2 cells treated with 1%, 3%, 10.5%, and 21% O2 for 24
hours. Data are means  SEM. * P < 0.05 vs. control (n = 5-15)
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Figure 3. Effect of hypoxia on methylation of the PKCε promoter. Methylation
patterns were determined in fetal hearts of maternal hypoxia and H9c2 cells treated with
1% O2 vs. 21% O2 for 24 hours. Data are means  SEM. * P < 0.05 vs. control (n = 5-10)
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Figure 4. Effect of methylation on SP1 binding. Nuclear extracts of H9c2 cells were
incubated with unmethylated (UM-oligo) or methylated (M-oligo) oligonucleotides
containing SP1 consensus sequence at sites -346 and -268.
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Figure 5. Effect of 5-aza-2’-deoxycytidine on PKC mRNA and protein. H9c2 cells
were treated with 1% O2 and 21% O2 for 24 hours in the absence or presence of increasing
concentration of 5-aza-2’-deoxycytidine (5-Aza-2’-dC). Data are means  SEM. * P <
0.05 vs. control (n = 4-17).
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Figure 6. Effect of 5-aza-2’-deoxycytidine on methylation of SP1 sites and SP1 binding.
H9c2 cells were treated with 1% O2 and 21% O2 for 24 h in the absence or presence of 30
µM 5-aza-2’-deoxycytidine (5-Aza). (A) Methylation of SP1 binding sites was determined
by methylation-specific PCR. (B) SP1 binding was determined by ChIP assays. Data are
means  SEM. * P < 0.05 vs. control (n = 4-9).
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Figure 7. Effect of hypoxia on SP1 methylation and PKC mRNA. Pregnant rats
were treated with hypoxia, and hearts were isolated from near-term fetuses or 3 months
old offspring. M, male; F, female. (A) Methylation of SP1 binding sites at the PKC
promoter. (B) PKC mRNA. Data are means  SEM. * P < 0.05 vs. control (n = 5)

50

Figure 8. Estrogen receptors and SP1 binding sites in the fetal heart. Hearts were
isolated from near-term fetuses. (A) Protein abundance of estrogen receptor alpha (ER)
and beta (ER) subtypes. Data are mean  SEM. * P < 0.05 vs. male (n = 5). (B) PCR
products of the SP1 binding sites (-346 and -268) following chromatin
immunoprecipitation (ChIP) with ER and ER antibodies, respectively, in the fetal
heart. M, markers.
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Figure 9. Effect of PKC activation on cardiac ischemia and reperfusion injury.
Hearts were isolated from 3-month-old male offspring that had been exposed to
normoxia (control) or hypoxia before birth, and were treated in the absence or presence
of the PKC activator -RACK (0.5 μM) for 10 minutes before subjecting to 20
minutes of ischemia and 30 minutes of reperfusion in a Langendorff preparation. Postischemic recovery of left ventricular developed pressure (LVDP) and end diastolic
pressure (LVEDP) were determined. Lactate dehydrogenase (LDH) release over 30
minutes of reperfusion was measured as area under curve (AUC). Data are mean 
SEM. * P < 0.05, hypoxia vs. control; † P < 0.05, + -RACK vs. --RACK. n = 5.
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Discussion
The present study demonstrates that hypoxia has a direct effect on fetal
cardiomyocytes causing a reduction in PKC protein and mRNA. This is correlated with
increased methylation of CpG dinucleotides in the two SP1 binding sites at the proximal
promoter region of PKC gene, resulting in decreased binding of SP1 to the promoter.
The causal effect of methylation in the hypoxia-induced PKC gene repression is
demonstrated through the use of a DNA methylation inhibitor, which blocks the
methylation and restores PKC mRNA and protein expression to normal.
Previous studies demonstrated the long-term adverse effect of maternal hypoxia
on cardiac vulnerability to ischemia and reperfusion injury in adult male offspring in a
sex-dependent manner.10,14,15 Particularly, the decreased expression of cardioprotective
genes, namely PKC in hearts of adult male offspring are of significant interest.14 Acute
hypoxia and reactive oxygen species increase the activity of PKC in the heart, which
plays an important role in cardioprotection during ischemia and reperfusion injury.30 The
present study demonstrated that chronic hypoxia during gestation down-regulated PKC
expression in the developing heart through an epigenetic modification. This suggests
differential regulations of acute hypoxia and chronic hypoxia on PKC activity and gene
expression in the heart. The causal role of reduced PKC in sex-dependent programming
of increased heart vulnerability to ischemia and reperfusion injury in adult male offspring
has been demonstrated by selective inhibition of PKCε with a PKCε translocation
inhibitor peptide.14, 31 The present study demonstrated that a selective PKC activator
peptide16, 27-29 restored the hypoxia-induced cardiac vulnerability to ischemic injury,
providing further evidence of cause-and-effect role of decreased PKCε in the hypoxia-
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mediated, sex-dependent programming of increased heart ischemic vulnerability in male
offspring. This is consistent with other studies showing that PKC expression is
necessary for acute cardioprotection during cardiac ischemia and reperfusion.19 The
present finding of decreased PKC protein and mRNA in fetal hearts caused by maternal
hypoxia suggests that the reduction in PKC expression observed in adult rats10,14
originates in utero. Previous studies in the same animal model demonstrated that
maternal hypoxia increased hypoxia-inducible factor 1 (HIF-1) protein in fetal hearts,
suggesting tissue hypoxia in the fetal heart.32 The similar results of isolated hearts treated
ex vivo with hypoxia indicate that hypoxia is necessary and sufficient to impact the PKC
expression in fetal hearts. Whether this decreased PKC expression in the heart is a
protective mechanism that increases fetal survival is not clear at present. However, the
finding that the down-regulation of PKC resulted in increased heart ischemic
vulnerability in offspring would suggest that it is a maladaptive response.
The present study used the embryonic rat ventricular myocyte cell line H9c233 to
investigate the underlying mechanisms. H9c2 cell line has been widely used in a variety
of myocardiocyte studies, including those investigating apoptosis, differentiation and
ischemia and reperfusion injury.34-38 H9c2 cells retain many electrophysical properties
found in freshly isolated cardiomyocytes,33 albeit they do not spontaneously contract and
are capable of continuous growth.39 In the present study, the hypoxia-induced decrease
in PKC expression observed in fetal hearts in vivo and ex vivo mirrored that found in
H9c2 cells, suggesting a congruent underlying mechanism for each model and providing
a comparable model of H9c2 cells in the study of PKC gene regulation. Similar to the
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present finding, it has been reported that PKC protein expression is decreased in H9c2
cells exposed to 2 and 8 h of hypoxia in the presence of low and high glucose.40, 41
Another question pertained to normal physiological PKC expression in fetal
heart cells. 21% O2 (147 torr) is generally considered normal for adult cells. Because fetal
partial oxygen pressures are closer to 20 torr,42 21% O2 is hyperoxic for fetal
cardiomyocytes. This may alter underlying gene expression patterns since normal oxygen
levels in fetal hearts are significantly lower. Interestingly, we found that exposure to
21%, 10.5% and 3% O2 had no significantly different effects on PKC expression in
H9c2 cells. While the potential effect of ‘hyperoxia’ on fetal cardiomyocytes remains to
be further investigated, the finding that 1% O2 down-regulated PKC expression suggests
modification in gene expression patterns as a mode of adaptation to oxygen insufficiency
in cardiomyocytes. This is in agreement with many previous studies in which hypoxic
effects were investigated in H9c2 cells under 1% O2.37,38,43,44
The finding of similar pattern of increased methylation of the two SP1 binding
sites at the PKC promoter between H9c2 cells and the fetal hearts of maternal hypoxic
treatment provides further evidence supporting the model of H9c2 cells in the present
study. Whereas the differences in methylation patterns in the putative Egr1 and MTF1 (168) binding sites observed in fetal hearts and H9c2 cells are intriguing, the functional
significance of this finding is not clear given that deletions of the regions containing the
Egr1 and MTF1 (-168) sites had no significant effects on the PKCε promoter activity.25
In contrast, deletion of the confirmed binding sites for both SP1 (-346) and SP1 (-268)
significantly decreased the PKCε promoter activity in H9c2 cells.25 In the present study,
we demonstrated by EMSA that methylation of CpG dinucleotides at the core of both
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SP1 binding sites abolished SP1 binding in H9c2 cells. Previous studies with site-directed
methylation of PKCε promoter-luciferase constructs selectively at SP1 binding sites at 268 and -346, demonstrated that mutation of CmG at either SP1 site -268 or -346 alone
had no significant effect on the promoter activity, but mutation of CmG at the both SP1
binding sites significantly reduced the promoter activity in H9c2 cells.24 Although
increases in nuclear SP1 protein abundance in hypoxic H9c2 cells may serve as a
compensatory mechanism, this increase is relatively ineffective because increased
methylation of SP1 binding sites caused an even more significant decrease in SP1
binding to the PKCε promoter in the intact chromatin as demonstrated by ChIP assays.
The finding that SP1 abundance was not significantly affected by hypoxia in fetal hearts,
as well as in the hearts of either male or female adult offspring, together with the finding
that hypoxia had no significant effect on SP1 binding affinity in H9c2 cells, fetal and
adult hearts, reinforces a primary role of methylation in programming of PKCε gene
repression.
The causal effect of increased methylation in hypoxia-induced PKCε gene
repression was further demonstrated with a DNA methylation inhibitor 5-aza-2’deoxycytodine in the present study. 5-Aza-2’-deoxycytodine binds to DNA
methyltransferase 1 causing its depletion and preventing DNA methylation,45 and has
been widely used to inhibit DNA methylation.46-49 In the present study, we demonstrated
that 5-aza-2’-deoxycytodine concentration-dependently inhibited hypoxia-induced downregulation of PKC mRNA expression. This is caused by inhibition of the hypoxiainduced methylation of both SP1 binding sites resulting in recovered SP1 binding to the
PKCε promoter in the intact chromatin. Whereas the study of 5-aza-2’-deoxycytodine in
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H9c2 cells is limited, relatively high concentrations of 5-aza-cytidine (a close derivative
of 5-aza-2-deoxycytidine) have been shown to rescue luciferase activity in transfected
H9c2 cells in excess of 250 µM,50 which may reflect cell-type specific response to 5-aza2-deoxycytidine and derivatives. The ability of 5-aza-2-deoxycytidine to restore PKC
mRNA and protein expression in cardiomyocytes in the presence of a stressor is
consistent with earlier studies that showed that 5-aza-2-deoxycytidine blocked cocainemediated repression of PKC expression in fetal rat hearts.24
Previous studies demonstrated that prenatal hypoxia caused an increase in heart
susceptibility to ischemia and reperfusion injury in a sex-dependent manner, which was
due to fetal programming of PKC gene repression resulting in downregulation of PKC
function in the heart of adult male offspring.14 In the present study, no significant
differences were found in SP1 methylation and PKC mRNA abundance between male
and female control groups in both fetuses and offspring. This is consistent with the
previous findings of no significant difference in PKC protein abundance in the heart
between control males and females.14, 51 However, the sex differences in hypoxia-induced
changes in methylation of the SP1 binding sites and PKCε transcription were
demonstrated in both fetal and offspring hearts. The finding that the hypoxia-induced
methylation was significantly greater in the hearts of male fetuses is intriguing given that
male and female fetuses are likely exposed to the similar concentrations of steroid
hormones in utero. Whereas the mechanisms are not clear at present, the sex difference
observed may be caused in part by the greater expression of ER and ER in the hearts
of female fetuses. The finding that both ER and ER interacted with the SP1 binding
sites at the PKCε promoter in intact chromatin in the fetal heart suggests a possible
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mechanism for the increased protection of SP1 binding sites and PKCε transcription in
the female hearts in response to hypoxic stress. It has been demonstrated that both ER
and ER can activate transcription of the retinoic acid receptor 1 (RAR-1) gene by the
formation of an ER-SP1 complex on the SP1 sites in the RAR-1 promoter.52 It is not clear
at present whether the presence of phytoestrogens in the diet of soy-based chows used in
the present study might contribute to the gender difference, though the pregnancy is a
stage of high estrogen concentrations. This remains as an intriguing area for the future
investigation using a casein-based diet. The similar pattern of sex differences in the
hypoxia-induced SP1 methylation and PKCε transcription demonstrated in the hearts of
male and female offspring supports the notion that fetal hypoxia-induced methylation of
CpG dinucleotides at the PKCε promoter contributes to PKCε gene repression in the
heart of adult offspring.
The present investigation provides evidence of a novel mechanism of methylation
in non-CpG island, sequence-specific transcription factor binding sites in subtle
epigenetic modifications of gene expression pattern in fetal programming of cardiac
function in response to adverse intrauterine environment. Although it may be difficult to
translate the present findings directly into the humans, the possibility that fetal hypoxia
may result in programming of a specific gene in the offspring with a consequence of
increased cardiac vulnerability provides a mechanistic understanding worthy of
investigation in humans. This is because hypoxia is one of the most important and
clinically relevant stresses to the fetus, and because large epidemiological studies indicate
a link between in utero adverse stimuli during gestation and an increased risk of ischemic
heart disease in the adulthood.
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Abstract
Aims: Fetal hypoxia causes promoter methylation and gene repression of protein
kinase C epsilon (PKCε) in the developing heart resulting in the heightened cardiac
susceptibility to ischemia and reperfusion injury in offspring. The present study tested the
hypothesis that HIF-1 and/or hypoxia-derived reactive oxygen species (ROS) mediate the
hypoxia-induced PKCε gene repression.
Methods and Results: Hypoxic treatment of pregnant rats from day 15 to 21 of
gestation resulted in significant decreases in PKCε protein and mRNA in fetal hearts.
Similar results were obtained in ex vivo hypoxic treatment of isolated fetal hearts and rat
embryonic ventricular myocyte cell line H9c2. Increased methylation of PKCε promoter
at the SP1 binding sites, -346 and -268, were demonstrated in both fetal hearts of
maternal hypoxia and H9c2 cells treated with 1% O2 for 24 h. In H9c2 cells, hypoxia
caused a significant nuclear accumulation of HIF-1α. HIF-1α inhibitors, YC-1 and 2methoxy estradiol, decreased the hypoxia-mediated HIF-1α nuclear accumulation, but
had no effect on the hypoxia-induced PKCε mRNA repression. Hypoxia produced a timedependent increase in the ROS production in H9c2 cells, which was blocked by ROS
scavengers N-acetylcysteine or 4-hydoxy tempo. In accordance, N-acetylcysteine and 4hydoxy tempo, but not apocynin, inhibited the hypoxic effect and restored PKCε protein
and mRNA expressions to the control values in the fetal heart and H9c2 cells. The ROS
scavengers blocked hypoxia-induced CpG methylation of the SP1 binding sites and
restored the SP1 binding to the PKCε promoter to the control levels.
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Conclusion: The results demonstrate that hypoxia induces epigenetic repression
of the PKCε gene through a NADPH oxidase-independent ROS-mediated pathway in the
fetal heart.

Keywords: PKCε, HIF-1α, ROS, DNA methylation, H9c2

Introduction
Epidemiological studies have demonstrated a clear association between an
adverse intrauterine environment and an increased risk of heart disease later in life [1-4].
Hypoxia is a common form of intrauterine stress. Animal studies have suggested a
possible link between chronic maternal hypoxia and increased risk of cardiovascular
disease in offspring [3-6]. Recent studies in rats have demonstrated that maternal hypoxia
results in the heightened cardiac vulnerability to ischemia and reperfusion injury in
offspring in a sex-dependent manner [6]. Additionally, it has been demonstrated that the
downregulation of protein kinase C epsilon (PKC) gene expression in the hearts of adult
offspring is a mechanism for the increased heart susceptibility to ischemia and
reperfusion injury in the animals exposed to hypoxia before birth [6,7]. PKCε plays an
important role in cardioprotection against ischemic injury [8-10]. Further investigation
has revealed that hypoxia has a direct effect on epigenetic repression of the PKCε gene in
fetal hearts through DNA methylation of the PKCε promoter at the SP1 binding sites [7].
However, the mechanisms underlying hypoxia-mediated methylation of the PKCε
promoter has yet to be elucidated.
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One of the most important mediators for the hypoxic effect is hypoxia inducible
factor 1 (HIF-1) that regulates many genes involved in external and internal adaptation to
hypoxic stress. HIF-1 is composed of two subunits, HIF-1β (constitutively active) and
HIF-1α (regulatory subunit). Although recent studies have implicated several
mechanisms for HIF-1α regulation, oxygen availability is classically described [11].
Under normoxic conditions, proline hydroxylases (PHDs) add hydoxyl groups to proline
residues 402 and 564, which afford the recruitment and binding of von Hippel-Lindau
protein (E3 Ligase). This event then primes HIF-1α for proteasomal degradation.
Additionally, factor inhibiting HIF (FIH) regulates the transcriptional activity of HIF-1
[12]. In normoxia, FIH hydroxylates arginine 803, preventing the association of HIF-1
and its binding partner CREB-binding protein (CBP)/p300 and thereby inhibits
transcriptional activity. Under hypoxic conditions, HIF-1α subunit stabilizes and
translocates to the nucleus where it dimerizes with HIF-1β. HIF-1 then interacts with
CBP/p300 and influences gene transcription through either direct binding to hypoxic
response elements (HRE), or indirect modulation of the activity or expression of other
transcription factors [13-15].
Another key mediator in the hypoxic effect is reactive oxygen species (ROS).
Under hypoxic conditions, intracellular ROS paradoxically increases [16]. The main site
for ROS production is the electron transport system (ETS) located in the inner membrane
of the mitochondria. Uncoupling of ETS caused by hypoxia slows the electron flow
through the ETS thereby increasing the probability of molecular oxygen interacting with
free radicals (i.e., semiubiquione) to produce superoxide ion [16,17]. Cardiomyocytes are
major producers of ROS due to their high metabolic demand. Increased ROS can
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significantly alter gene expression patterns through the induction of the integrated stress
response that involves PERK activation, eIFα phosphorylation and ATF4-mediated stress
gene induction [18]. Recent studies have suggested a link between prolonged oxidative
stress and aberrant DNA methylation patterns [19-21].
Since HIF-1 activity is central to cellular adaptation to hypoxic stress and
hypoxia-derived ROS is known to influence gene expression, it is plausible that HIF-1
and/or ROS may mediate the hypoxia-induced epigenetic repression of PKCε gene
expression in fetal hearts. The present study tests this hypothesis in fetal rat hearts and
rat embryonic ventricular cell line H9c2 that has been widely used in a variety of
myocardiocyte studies. Our recent study has demonstrated a congruent underlying
mechanism in fetal hearts and H9c2 cells in the epigenetic regulation of PKC gene
repression [7]. Herein, we present evidence that blockade of hypoxia-derived ROS, but
not HIF-1, inhibits the hypoxia-induced increase in methylation of the SP1 binding sites,
reverses the decreased SP1 binding to the PKCε promoter, and restores PKCε mRNA and
protein abundance to the control levels.

Methods
Experimental Animals
Time-dated pregnant Sprague-Dawley rats were purchased from Charles River
Laboratories (Portage, MI) and were randomly divided into two groups: 1) normoxic
control, and 2) hypoxic treatment of 10.5% oxygen from gestational day 15 to day 21, as
described previously (7). To examine the effect of antioxidant, the rats were treated in the
absence or presence of N-acetyl-cysteine (NAC, Sigma) in the drinking water (500
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mg/kg/day). Hearts were isolated from near-term (21 d) fetuses. For ex vivo studies,
hearts were isolated from day 17 fetal rats and cultured in M199 media (Hyclone, Logan,
UT) supplemented with 10% FBS and 1% penicillin/streptomycin at 37 C in 95% air/5%
CO2, as reported previously (7). Hearts were given 24 h of recovery time before being
placed in a hypoxic chamber with 1% O2 for 48 h in the absence or presence of NAC (1
mM). All procedures and protocols were approved by the Institutional Animal Care and
Use Committee guidelines, and followed the guidelines by US National Institutes of
Health Guide for the Care and Use of Laboratory Animals.

Cell Culture
H9c2 cells were obtained from ATCC (Rockville, MD, USA). Cells were
maintained in DMEM and supplemented with 10% FBS and 1% penicillin/streptomycin
at 37 C in 95% air/5% CO2. Cells were grown and sub-cultured in 6-well plates with
experiments performed between 70-80% confluent. For the hypoxic treatment, cells were
transferred to the hypoxic chamber and maintained at 1% O2 for 24 h, as previous
described (7).
Western Blot Analysis
Western blots were performed as previously described [7,14,22]. Briefly, hearts or
H9c2 cells were homogenized in a lysis buffer containing 150 mM NaCl, 50 mM
Tris.HCl, 10 mM EDTA, 0.1% Tween-20, 0.1% β-mercaptoethanol, 0.1 mM
phenylmethylsulfonyl fluoride, 5 µg/ml leupeptin, and 5 µg/ml aprotinin, pH 7.4 and
allowed to incubate for 1 h on ice. Homogenates were then centrifuged at 4C for 20 min
at 10,000 g, and supernatants collected. Nuclear extracts were prepared using the
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NXTRACT CelLytic Nuclear Extraction Kit (Sigma) with few modifications. Hypotonic
buffers were supplemented with 1 μM lactacystin and 1 mM EDTA. Protein
concentrations were measured using a protein assay kit (Bio-Rad, Hercules, CA).
Samples with equal amounts of protein were loaded onto 7.5 % polyacrylamide gel with
0.1% SDS and separated by electrophoresis at 100 V for 90 min. Proteins were then
transferred onto nitrocellulose membranes. Nonspecific binding was blocked for 1 h at
room temperature in the blocking buffer. The membranes were then probed overnight
with primary antibodies against PKCε (Santa Cruze Biotechnology; Santa Cruz, CA) and
HIF-1α (BD Biosciences), as described previously [23]. β-actin antibody (Sigma) was
used to normalize loading. After washing, membranes were incubated with IRDye®
secondary antibodies (LI-COR biosciences). Proteins were visualized and analyzed with
the Odyssey imagine system.

Real-Time RT-PCR
RNA was extracted from hearts or H9c2 cells using TRIzol protocol (Invitrogen,
Carlsbad, USA). PKCε mRNA abundance was determined by real-time RT-PCR using
Icycler Thermal cycler (Bio-Rad), as described previously [7]. The primers for PKCε are
5’-GCGAAGCCCCTAAGACAAT-3’ (forward) and 5’CACCCCAGATGAAATCCCTAC-3’ (reverse). Real-time RT-PCR was performed in a
final volume of 25 µl. Each PCR reaction mixture consisted of 600 nM of primers, 33
units of M-MLV reverse transcriptase (Promega, Madison, WI), and iQ SYBR Green
Supermix (Bio-Rad) containing 0.625 unit Taq polymerase, 400 µM each of dATP,
dCTP, dGTP, and dTTP, 100 mM KCl, 16.6 mM ammonium sulfate, 40 mM Tris-HCl, 6
mM MgSO4, SYBR Green I, 20 nM fluorescing and stabilizers. The following RT-PCR
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protocol was used: 42 °C for 30 min, 95 °C for 15 min, followed by 40 cycles of 95 °C
for 15 s, 59 °C for 20 s, 72 °C for 10 s. GAPDH was used as an internal reference and
serial dilutions of the positive control was performed on each plate to create a standard
curve. PCR was performed in triplicate, and threshold cycle numbers were averaged.

Quantitative Methylation-Specific PCR
DNA was isolated from hearts or H9c2 cells using a GenElute Mammalian
Genomic DNA Mini-Prep kit (Sigma), denatured with 2 N NaOH at 42 C for 15 min,
and treated with sodium bisulfite at 55 C for 16 h, as previously described [7,27]. DNA
was purified with a Wizard DNA clean up system (Promega) and resuspended in 100 µl
of TE buffer. Bisulfite-treated DNA was used as a template for real-time fluorogenic
methylation-specific PCR (MSP) using primers created to amplify promoter binding sites
containing methylation sites based on the previous sequencing of rat PKCε promoter
[23]. GAPDH was used as an internal reference gene. Real-time MSP was performed
using the iQ SYBR Green Supermix with iCycler real-time PCR system (Bio-Rad).

Measurement of Intracellular ROS
The fluorescent indicator 2’7’-dichlorofluorescein diacetate was used to measure
intracellular ROS in H9c2 cells. 2’7’-Dichlorofluorescein diacetate enters cells where it is
de-esterified and converted to the highly fluorescent 2′,7′-dichlorofluorescein (DCF)
upon oxidation. Cells were subcultured in black-wall, clear-bottom 96 well plates and
allowed to grow to 50-70% confluence. Cells were then exposed to hypoxic treatment at
various time points. After the treatment, cells were washed twice with PBS and then
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loaded with 5 μM of 2’7’-dichlorofluorescein diacetate in serum free DMEM and placed
in a 37 °C incubator for 30 min. Cells were removed from the incubator and washed
twice with PBS. Fluorescence (excitation wavelength at 495 nm and emission
wavelength at 515 nm) was measured using a Synergy HT Multi-Mode Microplate
Reader (Winooski, VT). All experiments were done with minimal exposure to light and
fluorescence was normalized to cell count.

Chromatin Immunoprecipitation (ChIP)
Chromatin extracts were prepared from H9c2 cells. ChIP assays were performed
using the ChIP-IT™ Express Chromatin Immunoprecipitation Kit (Active Motif,
Carlsbad, CA), as previously described [7,22]. Briefly, cells were exposed to 1%
formaldehyde for 10 min to crosslink and maintain DNA/protein interactions. After the
reactions were stopped with glycine, cells were washed, chromatin isolated and the DNA
sheared into medium fragments (200–1000 base pairs) with 7 pulses at ¼ power using a
sonicator. ChIP reactions were performed using a SP1 antibody (Active Motif) to
precipitate the transcription factor/DNA complex. Crosslinking was then reversed using
a salt solution and proteins digested with proteinase K. Two sets of primers flanking the
two SP1 binding sites at -346 and -268 were used: 5′-accatttcctctcgacatgc-3′ (forward)
and 5′-agatttcaacccggatcctc-3′ (reverse); 5′-agaggatccgggttgaaatc-3′ (forward) and 5′ctcacctacctttccgaaaca-3′ (reverse). PCR amplification products were visualized on 1.5%
agarose gel stained with ethidium bromide. To quantify PCR amplification, 45 cycles of
real-time PCR were carried out with 3 min initial denaturation followed by 95 °C for
30 s, 51 °C for 30 s, and 72 °C for 30 s, using the iQ SYBR Green Supermix with iCycler
real-time PCR system (Bio-Rad).
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Statistical Analysis
Data are expressed as mean ± SEM. Experimental number (n) represents the
hearts of fetuses from different dams. Statistical significance (P < 0.05) was determined
by analysis of variance (ANOVA) followed by Neuman-Keuls post hoc testing or
Student's t test, where appropriate.

Results
The Effect of HIF-1α Inhibitors on Hypoxia-Induced Decrease of
PKCε Expression
To assess the role of HIF-1α in hypoxia-induced decrease of PKCε expression,
YC-1 and 2-methoxyestradiol (2ME) were used to block HIF-1α nuclear accumulation.
YC-1 blocks HIF-1α protein by enhancing degradation [24], and 2ME blocks HIF-1α
through an oxygen and proteasome independent pathway that involves disruption of
mircotubules [25]. H9c2 cells were treated with 1% O2 for 24 h in the absence or
presences of YC-1 (10 or 100 μM) or 2ME (10 or 100 μM). Nuclear extracts were
collected for determining HIF-1α nuclear accumulation. Figure 1A shows that HIF-1α
protein accumulated in the nuclear compartment under the hypoxic treatment. The
addition of YC-1 or 2ME significantly reduced HIF-1α nuclear accumulation (Figure
1A). However, neither YC-1 nor 2ME had significant effects on the hypoxia-induced
decrease in PKCε mRNA expression (Figure 1B), suggesting the minimum role of HIF1α in regulating PKCε gene transcription under hypoxic conditions.
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The Effect of ROS Scavengers on Hypoxia-Induced Decrease of PKCε
Expression
To determine the role of ROS in hypoxia-induced decrease of PKCε expression,
the ROS scavengers, N-acetyl-cysteine (NAC) and tempol were used to reduce
intracellular ROS. H9c2 cells were treated with 1% O2 for 24 h in the absence or presence
of NAC (0.5, 0.75, 1 mM), tempol (1, 2.5, 5 mM). Additionally, apocynin (0.5 mM) was
used to determine the role of NADPH oxidase in the hypoxic effect. Hypoxia
significantly decreased PKCε protein and mRNA abundance (Figure 2A, B). NAC
produced a dose-dependent inhibition of the hypoxic effect on PKCε mRNA repression
(Figure 2A). Similar findings of blockade of the hypoxic effect were obtained with
tempol (Figure 2A). In contrast, apocynin had no significant effect on the hypoxiamediated downregulation of PKCε expression (Figure 2A). Consistent with the results of
mRNA, both NAC and tempol blocked the hypoxia-induced reduction of PKCε protein
expression in H9c2 cells (Figure 2B). In agreement with the findings in H9c2 cells,
maternal hypoxia-mediated downregulation of PKCε mRNA and protein expressions in
the fetal heart were blocked by NAC (Figure 3A). The similar results were obtained in
isolated fetal hearts treated ex vivo with 1% O2, showing the reversal of hypoxia-induced
downregulation of PKCε gene expression by NAC (Figure 3B).

Hypoxia Increased ROS Production in H9c2 cells
To determine whether hypoxia significantly alters ROS production in H9c2 cells,
we performed a time course experiment using 2’7’-dichlorofluorescein diacetate to
measure intracellular ROS production. H9c2 cells were treated with 1% O2 for 2, 4, 8, 16,
and 24 h. Fluorescence of DCF was measured using a microplate reader and normalized
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to cell count. As shown in Figure 4A, ROS levels were significantly elevated at the 2 h
treatment. At the 4 h time point, ROS levels peaked and gradually declined afterward
until the 16 h mark when it continued to increase again (Figure 4A). We further assessed
the effect of NAC or tempol on hypoxia-induced ROS production at the 4 h time point.
As shown in Figure 4B, in the presence of NAC or tempol, the hypoxia-induced ROS
production was blocked.

ROS Scavengers Abolished Hypoxia-Induced Methylation at the
PKCε Promoter
Previous studies have demonstrated prolonged hypoxia treatment significantly
increases methylation of the SP1 binding sites -346 and -268 at the PKCε promoter in
H9c2 cells [7]. We therefore determined whether the inhibition of ROS significantly
altered the methylation status of the SP1 binding sites at the PKCε promoter. H9c2 cells
were treated with 1% O2 for 24 h in the absence or presence of NAC or tempol. Genomic
DNA was isolated and methylation-specific PCR was performed using primers that had
been previously designed for the SP1 sites -346 and -268 [7,23]. Consistent with the
previous findings, hypoxia significantly increased the methylation status of the both SP1
binding sites in the absence of ROS scavengers (Figure 5A). NAC and tempol blocked
the hypoxia-induced increase in CpG methylation of the both SP1 binding sites -346 and
-268 at the PKCε promoter (Figure 5A). In agreement with the findings in H9c2 cells, the
maternal hypoxic treatment revealed a similar pattern of increased methylation of the two
SP1 binding sites, -346 and -268, at the PKCε promoter in the fetal hearts, which was
inhibited by NAC (Figure 5B).
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ROS Scavengers Restored SP1 Binding to the PKCε Promoter
Previous studies have demonstrated that methylation of the SP1 binding sites -346
and -268 decreases SP1 binding to the PKCε promoter resulting in the reduced
transcription activity [7,22]. To evaluate further whether the inhibition of ROS restored
the binding of SP1 protein to the SP1 binding sites at the proximal PKCε promoter in the
context of intact chromatin, ChIP assays were performed using the SP1 antibody. Figure
6 shows the binding of SP1 to both SP1 elements at −346 and −268 at the PKCε promoter
in intact chromatin in H9c2 cells. Hypoxia significantly decreased SP1 binding to the
both SP1 binding sites (Figure 6). In the presence of NAC or tempol, the SP1 binding
was restored to the control values for the both SP1 binding sites (Figure 6).
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Figure 10. The effect of HIF-1α inhibitors on PKCε expression. A, H9c2 cells were
treated with 21% O2 (control, C) or 1% O2 (hypoxia, H) in the absence or presence of
YC-1 (100 μM) or 2-ME2 (100 μM) for 24 h. HIF-1α protein in the nuclear extracts was
measured by Western blots. B, H9c2 cells were treated with 21% O2 (Control) or 1% O2
(Hypoxia) in the absence or presence of YC-1 (10, 100 μM) or 2-ME2 (10, 100μM) for
24 h. PKCε mRNA abundance was determined by real-time RT-PCR. Data are means 
SEM. * P < 0.05, hypoxia vs. control. n = 10-
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Figure 11. The effect of ROS scavengers on PKCε expression. A, H9c2 cells were
treated with 21% O2 (control) or 1% O2 (hypoxia) in the absence or presence of
apocynin, NAC or tempol for 24 h. PKCε mRNA abundance was measured by real-time
RT-PCR. Data are means  SEM. * P < 0.05, hypoxia vs. control. n = 5 B, H9c2 cells
were treated with 21% O2 (control, C) or 1% O2 (hypoxia, H) in the absence or presence
of NAC or tempol for 24 h. PKCε protein abundance was determined by Western blots.
Data are means  SEM. * P < 0.05, hypoxia vs. control. n = 4-9
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Figure 12. The effect of NAC on PKCε expression in fetal hearts. A, Hearts were
isolated from near-term fetuses of pregnant rats treated with control (C) and hypoxia
(H) in the absence or presence of NAC. B, Isolated fetal hearts were treated ex vivo
with control (C) and hypoxia (H) in the absence or presence of NAC. PKCε protein
abundance was determined by Western blots, and mRNA abundance was determined by
real-time RT-PCR. Data are means  SEM. * P < 0.05, hypoxia vs. control; † P < 0.05,
+NAC vs. –NAC. n =
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Figure 13. Measurement of intracellular ROS in H9c2 cells. A, H9c2 cells were
treated with 21% O2 (control) or 1% O2 (hypoxia) for 0, 2, 4, 8, 16, 24 h. Cells were then
loaded with 5 μM of 2’7’ dichlorofluorescein diacetate for 30 min and fluorescence
measured with a microplate reader. Data are means  SEM. * P < 0.05, hypoxia vs.
control. n = 4-8 B. H9c2 cells were treated with 21% O2 (control) and 1% O2 (hypoxia)
in the absence or presence of NAC or tempol for 4 h. Cells were then loaded with 5 μM of
2’7’ dichlorofluorescein diacetate for 30 min and fluorescence measured with a microplate
reader. Data are means  SEM. * P < 0.05, hypoxia vs. control. n = 5-6
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Figure 14. The effect of ROS scavengers on PKCε promoter methylation. A, H9c2
cells were treated with 21% O2 (control) or 1% O2 (hypoxia) in the absence (C) or
presence of NAC (N) or tempol (T) for 24 h. B, Hearts were isolated from near-term
fetuses of pregnant rats treated with control and hypoxia in the absence or presence of
NAC. Methylation of the SP1 binding sites at -346 and -268 was determined by
methylation specific PCR. Data are means  SEM. * P < 0.05, hypoxia vs. control. n = 4-
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Figure 15. The effect of ROS scavengers on SP1 binding to the PKCε promoter.
H9c2 cells were treated with 21% O2 (control) or 1% O2 (hypoxia) in the absence (C) or
presence of NAC (N) or tempol (T) for 24 h. SP1 binding to the PKCε promoter at -346
and -268 in the context of intact chromatin was determined by ChIP assays. Data are
means  SEM. * P < 0.05, hypoxia vs. control. n = 4-9

83

Discussion
The present study presents evidence for the first time that prolonged hypoxia
mediates epigenetic repression of the PKCε gene in the fetal heart through a ROS, but not
HIF-1α, dependent pathway. The studies demonstrate that the attenuation of hypoxiaderived ROS restores PKCε protein and mRNA expressions by inhibiting CpG
methylation of the SP1 binding sites and restoring SP1 binding to the PKCε promoter. In
contrast, the inhibition of HIF-1α did not affect the hypoxic effect on repression of the
PKCε gene.
The present study builds upon the recent work that demonstrated the heightened
cardiac susceptibility to ischemia and reperfusion injury in offspring that had experienced
prolonged hypoxia before birth [5,6]. Interestingly, the ventricles of these offspring
showed significantly less PKCε abundance compared to the control animals [6]. Previous
studies have shown that acute exposure to hypoxia increases the activity of PKCε in the
adult heart [26]. We have demonstrated that chronic gestational hypoxia decreases the
expression of PKCε in the fetal heart, suggesting that prolonged hypoxia in utero
suppresses PKCε gene activity [7]. Further investigation has revealed that chronic
hypoxia directly regulates PKCε gene expression through increased methylation of two
SP1 binding sites at the PKCε promoter [7]. This pattern of increased promoter
methylation was present from the fetal heart and persists into the adulthood [6,7].
Consistent with the increased methylation, SP1 binding to the PKCε promoter in the
context of intact chromatin was significantly decreased [7,22,23]. Site-directed
methylation of PKCε promoter-luciferase constructs for both SP1 sites, but not either site
alone, caused a significant decrease in the promoter activity in H9c2 cells, demonstrating
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an important epigenetic mechanism involving the two SP1 binding sites in regulating
PKCε gene transcription activity [7,22]. Furthermore, the causal role of DNA
methylation in the hypoxia-induced PKCε gene repression was demonstrated using a
methylation inhibitor, 5-aza-2-deoxycytdine that blocked the hypoxic effect on the
downregulation of PKCε gene expression, thereby restoring PKCε protein and mRNA to
the control values [7].
The present findings add new insights into the hypoxia-mediated regulation of
PKCε expression in cardiomyocytes and demonstrate that hypoxia-derived ROS mediates
the epigenetic repression of PKCε gene in the fetal heart. The finding that NAC and
tempol, but not apocynin, blocked the hypoxic effect on the PKCε repression is intriguing
and suggests a role of NADPH oxidase-independent ROS in the hypoxia-mediated effect
in the fetal heart. While NADPH oxidase has been shown to play a role in regulating the
ROS production under chronic hypoxic conditions in some cell types, particularly in the
pulmonary vasculature and carotid body, its involvement in hypoxia-mediated ROS
production and hypoxia-related gene regulation appears to be tissue and organ selective.
Consistent with the finding of minimum role of NADPH oxidase in the hypoxia-mediated
effect in the present study, previous studies in guinea pig ventricular myocytes
demonstrated that NADPH oxidase did not appear to contribute substantially in the
hypoxia-induced ROS production and myocyte dysfunction [27]. The present findings
that the ROS scavengers NAC and tempol inhibited hypoxia-mediated methylation of the
SP1 binding sites and restored SP1 binding to the PKCε promoter indicates that hypoxiaderived ROS plays a vital role in causing DNA methylation of the PKCε promoter in the
fetal heart. Similar findings showed that NAC significantly reduced global DNA
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methylation during anchorage blockade in murine nontumorigenic melanocyte,
supporting the notion that ROS plays an important role in regulating DNA methylation
[28]. Consistent with these findings, previous studies demonstrated that prolonged
exposure to ROS caused significant hypermethylation of the E-cadherin promoter [21].
ROS-mediated methylation of E-cadherin promoter involved up-regulation of Snail,
which recruited epigenetic effectors (i.e. DNA methyltransferase 1) to suppress gene
transcription. Interestingly, Snail overexpression alone was sufficient to induce
hypermethylation of E-cadherin promoter, suggesting Snail regulation was a key factor in
mediating epigenetic modification of gene promoters [21]. Determining whether Snail
activity is important in hypoxia-induced heightened methylation of CpG dinucleotides at
transcription factor binding sites for the PKCε promoter deserves further investigation.
Furthermore, understanding whether the mechanism by which hypoxia through ROS
mediates methylation of the SP1 binding sites is a broad event (occurring in many genes)
or selective (occurring in a few genes) warrants future research.
Previous studies in myocardial, non-myocardial tissues and H9c2 cell line have
found that hypoxia increases ROS [18,29,30]. Consistent with these findings, we found
that hypoxia significantly increased ROS in H9c2 cells using 2’7’-dichlorofluorescein
diacetate. Time course studies revealed a biphasic production of ROS in H9c2 cells with
an initial peak at 4 h treatment, which declined to the 16 h mark, then was significantly
increased by 24 h. Time course studies by Chen et al. [31] showed a similar biphasic
elevation of ROS in human embryonic kidney and glioma cell lines treated with
mitochondria complex inhibitor I rotenone or mitochondraia complex II inhibitor TTFA.
As shown in the present study, the prolonged hypoxia treatment for 24 h maintained
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significantly higher levels of ROS and produced heightened and prolonged oxidative
stress. Although acute exposure to ROS increases the activity of PKCε and promotes a
cardioprotective phenotype often observed in acute ischemia and reperfusion setting in
the adult heart [26], the present study demonstrates that prolonged hypoxia cause a
sustained increase in ROS that results in the downregulation of PKCε gene expression in
H9c2 cells. These findings suggest differential regulations of the PKCε activity and gene
expression in response to acute or chronic hypoxia. This difference may represent a
negative feedback loop where short-term hypoxia significantly enhances the PKCε
activity to promote a cardioprotective phenotype, while long-term exposure to hypoxiaderived ROS promotes adaptive changes that include the downregulation of PKCε gene
expression.
The present study found that H9c2 cells exposed to 1% O2 for 24 h resulted in
significant nuclear accumulation of HIF-1α that is a marker of hypoxia. This is consistent
with the previous study showing that maternal hypoxia increased HIF-1 protein levels
in the fetal heart [32], indicating tissue hypoxia of the fetal heart in response to maternal
hypoxia. Other studies have found that similar oxygen levels and exposure are sufficient
to induce HIF-1α stabilization and nuclear accumulation [33]. YC-1 and 2-ME have been
widely used to inhibit HIF-1α nuclear accumulation. Previous studies suggested that YC1 inhibited HIF-1α protein by enhancing its degradation through FIH-dependent COOHterminal transactivation domain (CAD) inactivation [24]. 2-ME inhibits HIF-1α
independent of oxygen and proteasome pathways by disrupting microtubules preventing
the translocation of HIF-1α into the nuclear compartment, thus preventing the HIF-1
activity [25]. Interestingly, both YC-1 and 2-ME have been shown to block HIF-2α
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nuclear accumulation as well, thereby inhibiting the HIF-2 activity. Although HIF-2α is
not the focus of this study, the use of YC-1 and 2-ME may also provide clues as to the
role of HIF-2α in hypoxia-induced PKCε gene repression.
Little is known concerning the role of HIF-1α in the methylation of specific gene
promoters [34]. HIF-1α regulates the expression of epigenetic effectors, namely histone
deacetylases and demethylase (JMJD1A) [35], but it is unclear whether HIF-1α directly
or indirectly regulates DNA methyltransferase (DNMT). Previous studies have shown
that HIF-1 regulates the c-myc activity [14]. C-myc has been shown to recruit DNA
methyltransferase resulting in promoter hypermethylation for some genes [36],
suggesting a possible mechanism whereby HIF-1 may influence methylation of promoter
regions. Interestingly, Watson et al. reported that chronic hypoxia increased global
methylation patterns and expression of DNA methyltransferase 3b in prostate cell lines
absent of HIF-1α protein expression [37], suggesting chronic hypoxia can influence DNA
methylation independent of HIF-1. In the present study, we found that the inhibition of
HIF-1α with YC-1 or 2-ME had no significant effect on hypoxia-induced repression of
PKCε mRNA, suggesting that HIF-1α does not play a significant role in altering PKCε
promoter methylation. Importantly, it has been demonstrated that hypoxia induces the
stabilization of HIF-1α protein through alterations in the redox state. The mechanism is
thought to be through mitochondrial derived ROS from complex III that regulate the
prolyl hydroxylases activity [20,38]. Other studies contend that oxygen availability
instead of ROS production is the main stimulus altering prolyl hydroxylase activity and
therefore HIF-1α stabilization [39]. In the present study, we demonstrate that attenuation
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of ROS, but not HIF-1α, plays a major role in hypoxia-induced reduction of PKCε
expression.
A model used in the present study was the embryonic rat ventricular myoctye cell
line H9c2. The H9c2 cell is a widely used system for studying cardiomyocytes, including
cell death, differentiation and fetal programming [7,29,32]. Electrophysically, H9c2 cells
are similar to primary cardiomyocytes, but differ phenotypically [40,41]. Although
differences exist, recent studies using the H9c2 cell line to study the effects of hypoxia on
PKCε abundance have found consistent results with freshly isolated fetal cardiomyocytes
and intact hearts [7]. Thus, H9c2 cells exposed to 1% O2 for 24 hours displayed a similar
pattern of decreased PKCε protein and mRNA as those seen in freshly isolated fetal rat
cardiomyocytes and intact hearts exposed to 1% O2 [7]. Furthermore, both models found
increased methylation of CpG dinucleotides at SP1 binding sites at the PKCε promoter.
This suggests the underlying mechanism for hypoxia-induced decrease in PKCε gene
expression is similar in both the freshly isolated fetal rat hearts and H9c2 cell line. Other
studies also demonstrated that prolonged hypoxia in the presence of low or high glucose
significantly decreased PKCε protein abundance in H9c2 cells [42,43]. Consistent with
these findings, the present study demonstrates a congruent underlying mechanism of the
heightened ROS in hypoxia-mediated PKCε gene repression in fetal hearts and H9c2
cells, supporting the use of the H9c2 cells in investigating the epigenetic mechanisms of
PKC gene expression patterns.
In summary, the present study identifies a novel mechanism of hypoxia-derived
ROS in inducing CpG methylation of sequence specific transcription factor binding sites
at the PKCε promoter and its gene repression in the fetal heart. Although it is difficult to
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translate directly these findings into humans, linking chronic exposure to hypoxia-derived
ROS with the downregulation of a cardioprotective gene has significance clinical
implications. Elevated levels of ROS have been implicated in numerous disease models
and thus, may initiate epigenetic modification of cardioprotective genes in long-term
leading to an increased susceptibility to ischemic heart disease. Potentially, this
knowledge may lead to interventions involving antioxidants defense during gestation that
may prevent the long-term adverse effects of chronic intrauterine hypoxia.
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CHAPTER 4
GENERAL DISCUSSION
Hypoxic stress is one of the most common insults to the developing fetus. Acute
exposure to hypoxia has beneficial effects on heart development. Short-term hypoxia
causes outflow tract remodeling and coronary vasculargenesis. However, chronic
pathophysiological hypoxia is associated with significant harmful effects that may
produce structural, functional, and gene expression changes in fetal heart that may persist
throughout life (Patterson and Zhang 2010). In rodents, chronic maternal hypoxia
induces hypertropic growth, and reduces proliferation of fetal cardiomyocytes. In adult
male offspring, chronic maternal hypoxia causes a significant increase in susceptibility to
ischemia reperfusion injury and considerably reduces the expression of the
cardioprotective gene PKC (Xue and Zhang 2009). PKC translocation inhibitors reduce
postischemic recovery in control animals, linking PKC gene regulation to protection
against ischemia reperfusion injury (Xue and Zhang 2009). Previous work in the cocaine
model of intrauterine stress has established DNA methylation of CpG dinucleotides at the
PKC promoter as the major mechanism for long-term repression of PKC. This study
establishes epigenetic repression through DNA methylation of PKC gene as the
principle process underlying long-term repression of PKC expression in fetal hearts
exposed to chronic maternal hypoxia. This study presents additional evidence that
oxidative stress independent of HIF-1 initiates events responsible for epigenetic
modification of PKC gene expression.
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The Direct effects of Hypoxia on Fetal Heart
In chapter 2, we demonstrated hypoxia significantly alters PKC protein and
mRNA in fetuses exposed to maternal hypoxia (10.5% O2) from day 15 through 21. This
finding builds on previous work that found maternal hypoxia significantly reduced PKC
expression in adult male offspring (Li et al, 2003, Xue and Zhang 2009). Our finding
supports studies done by Hlaváčková et al. (2010) who found chronic intermittent
hypoxia (CIH) significantly decreased PKC protein but did not alter phospho- PKC
levels in adult wistar rats. In addition, Hlaváčková et al. (2010) reported CIH increased
the total expression of total PKCδ and phospho-PKCδ. PKCδ expression has been linked
with increased ischemia reperfusion injury (Budas et al., 2007). The effect of chronic
maternal hypoxia on PKCδ expression in fetal hearts is not clear and deserves future
investigation.
Chronic maternal hypoxia effects fetal rat heart architecture by inducing
hypertropic growth, reducing cellular proliferation of fetal cardiomyocytes, reducing
metalloproteinase-2 activity, increasing collagen I and III expression and increasing the
heart to body ratio (Bae et al 2003, Xu et al, 2006). These findings suggest hypoxic
insult significantly alters fetal cardiomyocyte homeostasis, producing cellular and organ
specific changes that in the short term may be compensatory, but in the long term
increases the hearts susceptibility to cardiomyopathies in adulthood. In chapter 2, our
data confirmed that prenatal hypoxia causes intrauterine programming of rat offspring.
We found that selective PKC activation protects hearts exposed to maternal hypoxia,
thus supporting studies done by Inagaki et al. (2004), who demonstrated selective PKC
activation conferred in vivo protection against ischemic reperfusion injury in mice and
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porcine hearts. These findings place PKC regulation as central in conferring
cardioprotection in adult rat hearts.
Since maternal hypoxia can cause significant maternal stress that may result in
dramatic systemic adaptation, which may affect the fetus and account for the
downregulation of PKC and increased sensitivity to ischemia reperfusion injury, it was
necessary to determine the direct effect of hypoxia on fetal hearts. Therefore, we
demonstrated in chapter 2 by using a whole organ culture model that chronic hypoxia is
sufficient to induce a direct effect on PKC expression in fetal hearts. We exposed fetal
hearts to 1% O2 in cultured media for 48 hours and found significant reduction in PKC
protein and mRNA as compared to control. Similarly, cocaine exposure of culture intact
fetal hearts also resulted in significant decrease in PKC protein and mRNA (Meyer
2009B). These findings demonstrate hypoxia directly regulates PKC expression in fetal
rat hearts. The extent to which other maternal derived stressors induced by chronic
hypoxia such as increased circulating catecholamines or glucocortoids affects PKC
expression is not clear. In fetal sheep, chronic hypoxia modulates the fetal hypothalamicpituitary-axis (HPA) causing the elevation of in plasma precursor ACTH that allow for
heighten cortisol secretion in response to secondary stressor (Carmicheal et al., 1997;
Duscay, 1998; ). Chronic hypoxia also induces arterial sympathetic hyperinnervation,
elevation in epinephrine and noreprinephrine content in the heart (Jelinek and Jensen,
1991; Ruijtenbeek et al., 2000). These finding suggest additional factors produced by in
response to hypoxia may potentiate the effect of hypoxia on PKC expression. The
combined effect of hypoxia and stress hormones on cardioprotective genes such as PKC
is intriguing and warrants further study.
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The effect of Hypoxia In vitro
Although the use of maternal hypoxia and intact fetal heart models revealed
significant information pertaining the effects of hypoxia on rat heart, we determined to
use the cell culture model to study more closely the mechanisms responsible for PKC
repression. We selected the embryonic rat ventricular myoctye cell line H9c2. The
advantage in selecting the H9c2 cell line pertains to its unique fetal heart origin, which
afforded us a glimpse at fetal cardiomyocyte behavior from the controlled environment of
cell culturing. H9c2 cells retain many properties consistent with normal cardiomyocyte
physiology, including electrophysical characteristics (Hescheler, 1991). In addition, the
H9c2 cell line is used to study a variety of areas including cell death, differentiation and
ischemia reperfusion injury (Chong, 1998; Hwang, 2008; Graf, 2006).
There are obvious drawbacks in using a cell model. The cell model cannot
reproduce the microenvironment of the fetal heart. The fetal heart alone includes a variety
of cell populations such as fibroblast, endothelial cells, various types of cardiomyocytes
and neuronal cell types. Although paracrine and endocrine signaling cannot be
reproduced in this model, the use of the whole animal and intact heart model gives insight
into this process. The cell line selected does differ from normal freshly isolated fetal
cardiomyocytes. Freshly isolated cardiomyocytes are contractile and display a restricted
level of proliferation, whereas H9c2 are not contractile and under the right conditions are
capable of continuous proliferation. The H9c2 cell line may also differentiate into a
different phenotype over time with numerous passages, and therefore must be constantly
monitored. We were careful to confirm results obtained in the H9c2 cell line intact whole
hearts and hearts exposed to maternal hypoxia.
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In chapter 2 & 3, we demonstrated that PKC protein and mRNA was decreased
in H9c2 cells exposed to 1% O2 for 24 hours. This finding is consistent with the maternal
hypoxia and intact fetal heart models, which suggest that the underlying mechanism for
PKC repression is consistent across each model. Our findings are consistent with
studies that demonstrated prolonged hypoxia in the presence of low or high glucose
significantly decreased PKCε protein abundance in H9c2 cells (Kim 2003, 2004). In
tumor cells, chronic hypoxia significantly reduced PKCε protein causing increased
sensitivity to TNF-related apoptosis ligand (TRAIL) (Gobbi, 2010). Moreover, in chapter
3, we confirmed hypoxia-induced nuclear accumulation of HIF-1α in H9c2 cells, which
is consistent with studies that have demonstrated HIF-1α protein accumulation in fetal
hearts, H9c2 and freshly isolated cardiomyocytes cells (Bae et al, 2003; Hwang 2008;
Gobbi, 2010). Given these results, it seems H9c2 cells responds to hypoxia in a manner
consistent with normal cardiomyocytes and therefore supports the use of this model in
examining the underlying mechanism of hypoxia-induced gene repression.
An area of considerable discussion pertains to the use of 21% O2 as control for
cell culturing experiments. Since we chose to study fetal cardiomyocytes, the question of
what is normal physiological oxygen tension is critical. Fetal cardiomyocytes develop at
low pO2 values as compared to normal adult cardiomyocytes (Patterson and Zhang,
2010). Some studies have found fetal oxygen tension to be as low as ~20 mm Hg
(Bishai, 2003; Webster 2007). In addition, fetal cardiomyocytes utilize large amounts of
oxygen due to high metabolic activity (Ascuitto and Ross-Ascuitto, 1996). This suggests
that normal physiological oxygen tension for fetal cardiomyocytes is significantly lower
than the 21% O2 (~147 mm Hg) used in standard culturing techniques, which could
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significantly distort results. These concerns were also highlighted in a review by Dr.
Ivanovic (2009), who argued that standard culture condition do not reflect normal oxygen
tension levels in a variety of tissues (i.e. bone marrow) in the mature organ system. He
argued the term normoxia, which represented 21% O2 in classical physiology was also
adopted in cell biology and culturing but is not an accurate representation of normal for
tissue and cell environments (Ivanovic 2009). We also recognized these concerns when
considering the H9c2 cell model. In chapter 2, we designed experiments using various
levels of oxygen tension and demonstrated that there was no difference in PKC protein
or mRNA when we used 21% (~147 mm Hg), 10.5% (~73.5 mm Hg) or 3% (~21 mm
Hg) O2, but found significant differences in PKC protein and mRNA at 1% (~7 mm Hg)
O2. Furthermore, in chapter 3 we demonstrated nuclear accumulation of HIF-1α protein
at 1% O2, while no HIF-1α protein could be detected at 21% O2. These findings support
our hypothesis that the H9c2 model system using 21% O2 as control and 1% O2 as
hypoxia is consistent with the maternal hypoxia model and is ideal for studying the
molecular mechanisms regulating PKC expression.

PKC Regulation
The regulation of PKC expression under hypoxic condition is the focus of this
project. Normally, PKCε expression increases 10-fold in the rat heart from neonatal to
adult periods (Clark et al., 1995). Our lab has shown maternal hypoxia from day 15 to 21
of gestation resulted in increase sensitivity to ischemia reperfusion and injury and
decrease PKC abundance in the ventricles of adult male rats (Li, 2003; Xue and Zhang
2009). Interestingly, researchers have demonstrated no significant change in the ratio of
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phospho-PKC/ PKC between control and maternal hypoxia groups, suggesting PKC
activity is not affected by chronic gestational hypoxia (Xue and Zhang 2009). In chapter
2, we showed that hypoxia directly regulates PKC abundance in isolated intact fetal
heart and H9c2 cells. Studies examining the effect of cocaine and nicotine through
catecholamines on PKC expression have found concurrent findings with the hypoxia
model, suggesting a similar pattern of PKC regulation (Meyer 2009B; Lawrence 2008).
In fact, cocaine and nicotine exert vascular altering properties that may affect fetal
oxygen supply (Wood, 1987; Lawrence, 2008). Indeed, these findings may shed clues as
to a general mechanism for adaptation to intrauterine stress and the consequences in
terms of PKC gene regulation in fetal heart.
Our lab has found cocaine directly regulates PKC gene repression through
increased DNA methylation for transcription factor binding sites of PKC promoter
(Meyer 2009B). Specifically, cocaine treatment significantly increased methylation at
Sp1 binding sites -346 and -268 and this significantly reduced binding of SP1 to those
sites (Meyer 2009B). In chapter 2 & 3, we found chronic hypoxia also significantly
increased methylation of SP1 binding sites -346 and -268. We confirmed with EMSA
assays that methylation at the core of SP1 binding sites -346 and -268 abolished SP1
binding and that hypoxia does not significantly alter the binding affinity of SP1 protein to
SP1 binding sites -346 and -268. Reporter gene assay indicated the regions
encompassing SP1 binding sites -346 and -268 play a significant role in promoter activity
(Zhang 2009). While methylation of a single SP1 site does not substantially alter PKC
promoter activity, methylation of both SP1 sites (-346 and -268) significantly decreases
PKC promoter activity (Meyers, 2009B). In H9c2 cells, we demonstrated with CHIP
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assay that chronic hypoxia decreases the binding of SP1 protein to Sp1 binding sites -346
and -268 in vivo and that SP1 binding is restored in the presence of DNA methylation
inhibitor 5-aza-2-deoxycytidine. This finding supports previous work that found cocaineinduced repression of SP1 binding is restored in the presence of DNA methylation
inhibitors 5-aza-2-deoxycytidine and procainamide (Meyer, 2009). We further
demonstrated that 5-aza-2-deoxycytidine blocked the hypoxic effect on PKC protein and
mRNA, definitively linking epigenetic repression through CpG dinucleotide methylation
as chief mechanism of hypoxia-induced PKC repression (See Figure 16). The observed
heightened sensitivity of the PKCε promoter to methylation in response to cocaine,
nicotine and chronic hypoxia in fetal hearts is intriguing and suggest a common pathway
of regulation in response to intrauterine stress.
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Figure 16: Plausible mechanisms for hypoxia-induce downregulation of PKCε in
hearts. Hypoxia causes the stabilization of HIF-1α and increases ROS production in fetal
hearts. Increase ROS causes the recruitment of epigenetic modifiers, i.e. DNA
methyltransferase (DNMT) and possibly histone deacetylases (HDAC). These modifiers
increase methylation of promoter at transcription factor binding sites and deacetylate
histone residues resulting in the decreased transcription of PKCε.
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We have presented data showing PKCε expression is altered in utero in the hearts
of fetus exposed to chronic maternal hypoxia. It is not clear, however, the affect of
chronic hypoxia on PKCε gene expression in other organ systems such as in brain or liver
and the long-term implication. Studies in brain have found PKC is important in
preconditioning of ischemia reperfusion injury (Raval AP, 2003; Kim et al., 2007). PKC
also plays an important role in hyperalgesic priming, a process whereby one or several
acute inflammatory events involving pain becomes a chronic condition with heightened
pain sensation (Reichling D, 2009). PKC plays an important role in nociceptors
progression from acute to chronic pain sensitization (Reichling D, 2009). Interestingly,
the selective activation of PKCε with bryostatin1 or DCP-LA has been shown to reverse
or prevent synaptic lost in the hippocampus, reduced Aβ protein accumulation and
improve cogitative memory in Alzheimer’s disease models (Hongpaisan et al., 2011). In
each model, oxidative stress has been shown to contribute to disease progression.
Perhaps, ROS-signaling may be the common pathway modulating PKCε expression. The
apparent involvement of PKC in multiple organ systems suggests that perinatal
regulation of PKC expression has important implications for a variety of diseased and
non-diseased states later in life.

DNA Methylation
DNA methylation is the chief mechanism for transcriptional repression.
Methylation of cytosine plays an important role in normal physiology. Among other
examples, genomic imprinting during early stages of development utilizes DNA
methylation (Okano et al., 1999; Miranda and Jones 2007). Differentiation of stem cells
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into specialized tissue such as cardiomyocytes, neurons, and hepatocytes involves
selective repression of genes through DNA methylation. The role of DNA methylation in
fetal programming of disease is intriguing. A classic example of the importance of DNA
methylation in gestational epigenetics is found in studies done in the Agouti mouse
model (Waterland and Jirtle, 2004). Avy/a mice display a range of fur colors from yellow
to mottle to brown (Waterland and Jirtle, 2004). The yellow agouti (Avy) mouse has a
mutation that causes yellow pigmentation. When pregnant yellow agouti (Avy) mice were
supplement with methyl rich or high soy diets, the fur of the offspring shifted towards
brown fur color, and in the case of the high soy diets significantly reduced the weight of
brown offspring in comparison to yellow (Dolinoy, 2006). In comparison, reduced folate
intake during pregnancy can lead to genetic instability with abnormal chromosomal rearrangement as result of poor gene regulation due to hypomethylation (Okano et al.,
1999). Methyltetrahydrofolate (folate) is an important methyl donor to S- adensonyl
Methionine (SAM). DNA methylation is mediate by a family of enzymes known as DNA
methyltransferases (DNMT). DNMT uses methyl groups from SAM to methylate CpG
dinucleotides of target genes. It is not clear whether DNMT expression or activity is
altered by hypoxic insult. Studies in prostate cell line PwR-1E have shown increased
DNMT3b (a isoform responsible for de novo methylation) activity in response to chronic
hypoxia (Watson, 2009). The effect of hypoxia on the activity of DNMT’s and global
methylation patterns in fetal cardiomyocytes is an area yet to be elucidated. We have
found that in response to chronic hypoxia, fetal cardiomyocytes adjust gene expression
patterns through targeted methylation of SP1 binding sites at the PKC promoter. The
term “targeted” is used since the methylation levels for most transcriptional factor
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binding sites with CpG dinucleotides in the proximal PKCε promoter (except MTF1-2 168) were not significantly changed as a result of chronic hypoxia (See chapter 2, figure
3). Only Sp1 binding sites (-346, and -268) in both H9c2 and fetal hearts and Egr1 (1008) in fetal hearts were significantly increased by chronic hypoxia. Methylation of Sp1
binding sites does not completely abolish gene transcription but significantly reduces
basal levels (Zhang, 2009), which leads to heighten sensitivity to stress in adult life.
Interestingly, our lab has reported similar patterns of methylation for PKC promoter in
cocaine (Sp1) and nicotine (Egr1) models of intrauterine stress (Zhang, 2009; Lawrence
2011). It is unknown whether the process of methylation of PKC in cardiomyocytes is
present in other forms of intrauterine stress such as undernutrition, alcohol exposure, or
elevated stress hormones. Moreover, the effect of chronic intrauterine hypoxia on the
methylation status of the PKC promoter in other tissues such as brain is not known and
warrants future study.

Hypoxia and Sex Dimorphism of Cardiac Vulnerability
Previous studies have reported significant sex differences in the effect of maternal
hypoxia on cardiac vulnerability in adulthood. Maternal hypoxia causes increase
susceptibility to ischemia reperfusion injury in male rat offspring (Xue and Zhang 2009).
Further investigation revealed reduced expression of PKC protein in male rats compared
to female rats. In chapter 2, we demonstrated maternal hypoxia caused significant
decrease in PKC mRNA and increase methylation of both SP1 bindings sites (-346 and 268) for fetuses and adult offspring. The degree to which methylation was increased in
female hearts was considerably lower than in male hearts. Fetal hearts exposed to
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maternal cocaine responded in a similar sex dependent manner (Zhang, 2009). Maternal
cocaine exposure caused increase CpG methylation for SP1 binding sites -346 and -268
in male and -268 only in female offspring (Zhang, 2009). Likewise, maternal nicotine
exposure caused increased susceptibility to ischemia reperfusion injury in both male and
female offspring, with poorer recovery in female offspring (Lawrence 2008). PKC
protein was significantly reduced in both male and female hearts exposed to prenatal
nicotine, which suggest nicotine induces a different pattern of regulation in fetal hearts
(Lawrence, 2008). Furthermore, Netuka et al. (2006) found maternal hypoxia
significantly improved cardiac tolerance to ischemic arrhythmias in female offspring, but
had the opposite effect in male offspring. These findings indicate sex dependent
mechanisms for in utero programming of the myocardium.
Studies have found a general tendency for female offspring to be more resistant to
cardiovascular diseases induced by prenatal stressors (Zhang 2009, Xue 2009). Indeed,
cardiomyocytes isolated from female hearts are more resistant to ischemia reperfusion
injury (Rank et al. 2001). Sex specific differences in gene expression become evident by
midgestation in rodents (Dewing 2003). The contribution of (XX) and (XY) dependent
genes in reduced or enhanced cardioprotection of male or female offspring respectively,
is not clear. In neonatal brains, a PARP1 knockout potentiate differences in relative
NAD+ utilization and expression between male and females, and has therefore been
proposed as a contributing factor in increased sensitivity of male neonates to ischemia
reperfusion injury (Hurn, 2005). The increase cardioprotection observed in female
offspring may inpart be explained by the presence of estrogens sex hormone. Removal of
the ovaries and estrogen replacement in rats has implicated estrogens in cardioprotection
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against ischemia reperfusion injury in female rat hearts (Zhai et al. 2000). The exact
mechanism is not clear, but studies in female rat hearts have found estrogens replacement
reduced the expression of tumor necrosis factor-alpha (Xu 2006). Further studies have
found estrogen receptor alpha agonist (4,4',4''-[4-propyl-(1H)-pyrazole-1,3,5-triyl]trisphenol [PPT]) or selective beta agonist (2,3-bis(4-hydroxyphenyl)-propionitrile [DPN])
improve myocardial recovery from acute ischemia reperfusion insult (Vornehm 2009).
These findings are interesting given that male and female fetuses are likely exposed to
similar concentration of steroid hormones. In chapter 2, we demonstrated significant
higher expression of ERα and ERβ in female fetal hearts compared to male, which may in
part explain the enhanced protection afforded in female hearts. Furthermore, we
demonstrated using ChIP assay that ERα and ERβ interact with SP1 binding sites -346
and -268 at PKC promoter. The functional significance of this interaction is yet to be
understood, however, several studies examining multiple genes have demonstrated ERα
and ERβ are capable of binding GC rich regions and forming ER-SP1 complexes that are
important in gene transactivation (Safe, 2008; Sisci 2010; Nilsson 2001). The relative
gender differences in PKC promoter methylation and ERα and ERβ expression in utero
are fascinating and deserve future study.

HIF-1α and Epigenetic Repression of PKC Gene
HIF-1α plays an important regulatory role in cellular and tissue adaptation to
hypoxic stress. HIF-1α influences the expression of genes involved in apoptosis, cellular
differentiation, metabolism and cell signaling (Semenza, 2007). Previous work in our
lab and has demonstrated increased HIF-1α expression in the fetal rat hearts exposed to
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maternal hypoxia in late gestation (Bae et al., 2003). Studies in the developing chick
embryo have also demonstrated HIF-1α stabilization (Sugishita et al., 2004A). In fetal
heart development, HIF-1α plays a critical role in modulating cardiomyocyte survival and
death pathways, thereby orchestrating remodeling events during cardiogenesis (Sugishita
et al, 2004A; Patterson and Zhang, 2010). The role HIF-1α plays in epigenetic
modulation through methylation of CpG dinucleotides is not well understood. To our
knowledge, interaction between HIF-1 and DNMT has not been described. HIF-1α has
been reported to interact with histone modulators such as histone deacetylases and
methylases (Granger 2008; Beyer 2008). In particular, HIF-1 transactivates histone
demethylase JMJD1A, JMJD2A, JMJD2B, and JMJD2C (Wellman et al. 2008).
JMJD1A and JMJD2A remove dimethyl marks on histone 3 lysine 9 (H3K9me2), while
JMJD2B removes trimethyl marks (H3K9me3) and more weakly JMJD2C which
converts H3K9me3 to me2 (Xia et al. 2009; Pollard et al. 2008; Maltepe et al. 2005;
Charron et al. 2009). H3K9 methylation produces compaction of chromatin thereby
decreasing exposure of DNA to damage. H3K9 demethylation is one epigenetic
mechanism that is thought to be link to chronic inflammation and HIF-1 activity in
carcinogenesis (Brigati 2010). Additionally, chemically induced hypoxia in prostate
cancer cell lines induces HIF-1 stabilization with concurrent reduction in miR-101 (Cao,
2010). Although the researchers in this study did not distinguish between the ROS and
HIF-1 effects, this finding implies that hypoxia via HIF-1 may modulate micro-RNA
expression suggesting an additional role for HIF-1 in epigenetic regulation.
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In chapter 3, we demonstrated inhibition of HIF-1α with YC-1 or 2-me2 did not
attenuate the hypoxia-induced repression of PKC mRNA, suggesting HIF-1 does not
play a significant role in epigenetic repression of PKC gene (See Figure 16). Since YC1 and 2-me2 have been shown to diminish HIF-2α nuclear accumulation, it is unlikely
HIF-2 plays a significant role in epigenetic repression of PKC. The role of HIF-3 in
epigenetics is unknown. However, studies using a dominant negative HIF-3alpha splice
variant suggest HIF-3 negatively regulates HIF-1 & 2 activity (Maynard 2007).

Hypoxia, Oxidative Stress and PKC
The role of oxidative stress during hypoxia is a fascinating area of research.
Studies have shown hypoxia increases ROS in cardiomyocytes resulting in reduced
contractility (Duranteau et al. 1998). In Chapter 3, we demonstrated chronic hypoxia
increases ROS in H9c2 cells. The exact mechanism is not clear, however the consensus in
the field suggests complex III of the mitochondrial electron transport chain is the primary
sites of ROS generation during hypoxia (Galansis et al., 2008). Interestingly, a recent
study found mitochondrial derive ROS plays a critical role in cardiac hypertrophy and
failure (Dai et al., 2011). We demonstrated in chapter 3 that N-acetyl cysteine or tempol,
but not apocynin (NADPH oxidase inhibitor) blocked hypoxia-induced repression of
PKC protein and mRNA in hearts exposed to hypoxia pregnant rats from day 15 to 21 of
gestation, in isolated whole fetal hearts, and H9c2 cells, implicating oxidative stress in
the hypoxia-induced decrease PKC expression. Although NADPH oxidase has been
shown to regulate ROS production under chronic hypoxic conditions in some cell types,
its role in hypoxia-induced repression of PKCε expression is minimal. Our lab has also
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found cocaine induce repression of PKCε in fetal hearts involves oxidative stress that is
independent of NADPH oxidase activity (unpublished data). This finding further
supports the concurrent mechanism of in utero repression of PKCε expression.
Interestingly, acute exposure to ROS increases the activity of PKCε by promoting the
translocation from cytosolic to particulate fraction and thus a cardioprotective phenotype
often observed in acute ischemia and reperfusion models (Golberg et al., 1996; Kabir et
al., 2006). These finding suggests ROS differentially regulates PKCε gene, perhaps
through a negative feedback loop that is dependent on the duration of the insult (See
Figure 17). This implies that while short bouts of hypoxia are protective by stimulating
PKCε activity, long-term hypoxia significantly reduces PKCε expression thereby
considerably reducing the threshold necessary for cell death to occur. Interestingly, NAC
attenuates apoptosis and ischemia reperfusion injury in H9c2 cells and ex vivo neonatal
rabbit hearts (Peng et al., 2011). Although PKCε expression was not examined in this
study, the notion that antioxidant defense protects against ischemia reperfusion injury
supports our findings that PKCε gene activity is maintained at basal levels in the presence
of NAC. Previous work in our lab has shown a cause and effect relationship between
PKCε expression and postischemic recovery (Li et al., 2003; Xue et al., 2009). Perhaps,
the preservation of PKCε expression with antioxidant exposure during chronic maternal
hypoxia will improve postischemia recovery in those animals.
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Figure 17: The short and long term effects of ROS on PKCε in cardiomyoctes.
Hypoxia causes the increase reactive oxygen species (ROS). Acute exposure to ROS
causes PKCε migration from soluble to particulate fraction which is indicative of
increase activity and cytoprotection. Chronic exposure to ROS induces reduced PKCε
expression and concurrent reduced cardioprotection.
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Recently, the connection between oxidative stress and epigenetics has gained
interest. Studies using superoxide dismutase knockout mice have found increased
oxidative stress associate with reduce global DNA methylation (Bhusari et al., 2010).
Generation of free radicals through X-ray, UV, and γ-rays causes widespread DNA
damage that significantly reduces the methyl-accepting ability of DNA (Wilson and
Jones, 1983; Becker et al., 1985; Kalinich et al., 1989). The presence of 8-OHdG in CpG
dinucleotides has also been shown to significantly impede methylation of adjacent
cytosines (Weitzman et al., 1994; Turk et al., 1995). The presence of single stranded
DNA can signal De novo methylation (Christman et al., 1995). Perhaps the presence of
single strand breaks caused by oxidant damage may promote aberrant methylation
patterns that can lead to disease progression. Indeed, oxidative damage reduces global
methylation but increases regional methylation patterns. Studies in tumoriogenesis have
found hypoxia mediates suppression of E-cadherin expression through methylation of Ecadherin promoter in ovarian carcinoma (Imai et al., 2003). The mechanism involves an
increase in oxidative stress that promotes epigenetic modification of E-cadherin promoter
through CpG methylation that is SNAIL dependent (Imai et al., 2003; Cannito et al.,
2008). Furthermore, we found ROS scavengers blocked hypoxia-induced methylation of
PKC promoter suggesting oxidative stress plays an important role in regulating PKC
promoter methylation. Interestingly, studies have found certain fruits and vegetables
protect against aberrant methylation in prostate cells, which further supports the use of
antioxidants in protection against oxidative damage that leads to mutagenic processes
(Ornish et al., 2005; Donkena et al., 2010). Together, these findings reflect a complex
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system of regulation involving cellular adaptation to hypoxia-induced oxidative stress
and the in utero programming PKC expression (Figure 16).

Clinical Significance
The clinical significance of this project is immense. Hypoxia is one of the most
common gestational insults. Hypoxia during critical periods of development can alter
organ and tissue maturation. There is an increased risk of fetal hypoxia in pregnancy
where there is cord compression, preexisting maternal illness, smoking, drug use,
placenta abnormalities and high altitude (Zhang 2005; Patterson 2010). Our study
indicates that chronic hypoxia during the latter stages of fetal rat heart development
causes the epigenetic modification of PKC promoter leading to reduced PKC
expression. We were able to demonstrate that ROS scavenging with NAC was able to
block the hypoxia-induced methylation of PKC promoter and reduced expression. The
clinical importance of linking oxidative stress to hypoxia-induced repression of PKC in
utero is profound. Currently, clinical studies are examining the role of pregestational
diabetes during pregnancy in altering the epigenetic landscape of the fetus
(NCT01255384). The rationale for this study is based on the understanding that the
diabetic environment increases oxidative stress and causes significant changes in gene
expression that may involve epigenetic mechanisms. In addition, a recent clinical study
examining the effect of NAC on the prevention of preterm delivery has recently
completed phase IV trials (NCT00568113). The results from this study are yet to be
reported, however, it raising the issue that oxidative stress is important in the fetal
development and disease. The implication of oxidative stress in hypoxia-mediated
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epigenetic repression may influence future clinical studies examining intrauterine stress
and fetal outcomes.
PKC plays a critical role in myocardial protection against ischemia reperfusion
injury. In the rat model, chronic maternal hypoxia causes long-term repression of PKC
expression in myocardial tissue leading to enhance vulnerability to ischemia reperfusion
later in life. We have demonstrated that chronic hypoxia represses PKC expression
through methylation of CpG dinucleotides at the PKC promoter. PKC is involved in a
wide array of physiological and pathophysiological processes. PKC is expressed in
tissues throughout the body and has been implicated in precondition against ischemia
reperfusion injury, oncogenesis, addiction, hyperanalgesia and thrombosis (Rechling and
Levine, 2009; Harper and Poole, 2010; Ardehali, 2006; Barnett, 2007; Lesscher, 2009).
The intrauterine regulation of PKC in cardiomyocyte may reflect broader regulation of
PKC and other protective genes, placing gestational epigenetics as critical to
understanding adult disease. Currently, there are several clinical trials examining the
effect of selective inhibition of several PKC isoforms. One example involves a doubleblinded randomized clinical study examining the efficacy of using KAI-9803 to block
PKCδ in reducing infarct size in-patient with myocardial infarction undergoing a
percutaneous coronary intervention (NCT00785954). PKC on the other hand is fairly
unstudied clinically. However, clinical trials are examining the efficacy in using
selective PKC blockers (KAI-1678) for the treatment of postoperative pain and PKC
activators (Bryostatin) in treating Alzheimer disease (NCT01015235, NCT00606164).
Perhaps, in utero programming of PKC gene may have tissue specific patterns and
therefore influence the function of several organ systems. In myocardial studies, PKC is
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used as a primary outcome indicator for the use of blood pressure cuff induced
preconditioning in patients recovering from heart surgery (NCT00546390). Indeed,
chronic oxygen insufficiency in utero may suppress or deregulate genes in myocardial
and nonmyocardial tissues, reducing the organ systems ability to adapt to insults later in
life. With an increased understanding of hypoxia-induced intrauterine modulation of
PKC expression in fetal hearts, preventative and therapeutic measures may be employed
to improve patient outcomes.

Future Studies
The findings observed in this project have produced several questions that warrant
further investigation. We found hypoxia mediates repression of PKCε expression
through CpG dinucleotide methylation of Sp1 binding sites. The mechanism involves
oxidative stress dependent pathways. We demonstrated in an in vivo, ex vivo, and H9c2
cell line model that ROS scavengers block the hypoxia-induced repression of the PKCε
gene. The functional significance of this finding suggests attenuation of oxidative stress
in utero will improve postischemia reperfusion recovery in adult rat hearts. However, it
has not been determined whether attenuation of maternal hypoxia-derived oxidative stress
translates into improved postischemia recovery in adult rat offspring. Attenuation of
hypoxia-derived oxidative stress maintains basal expression of PKCε in fetal rat hearts
and therefore would likely improve cardiac performance in adult offspring, but this has
not been proven experimentally. Interestingly, when Wistar rats exposed to
undernutrition during fetal development were pretreated with NAC for 48 hours 6 months
after delivery, they showed improved recovery from ischemia reperfusion injury (Elmes
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et al., 2007). Furthermore, determining whether the use of antioxidants such as vitamin
A, C or E can produce effects similar to NAC is of considerable importance. Previous
studies have shown Vitamin A, C, and E given during late gestation reduces hypoplasia
associated with congenital diaphragmatic hernia in fetal rat hearts exposed to Nitrofen
(Gonzalez-Reyes, 2005). Vitamin A, C and E are found in numerous plant-based foods
and are widely consumed in the general population. If the actions of the vitamins mirror
those of NAC in the in vivo, ex vivo, and H9c2 models, then this may provide a natural
therapeutic model to protect fetal hearts from intrauterine stress.

Oxidative Regulation of PKCε
In chapter 3, we demonstrated that maternal hypoxia represses PKCε promoter
through an ROS dependent pathway involving methylation of CpG dinucleotides for Sp1
binding sites. The primary source of hypoxia-derived ROS was reported to originate in
Complex III of the electron transport chain (Guzy & Schumacker, 2006). The
mitochondrial production of ROS via complex III is also reported to regulate HIF-1α
stability (Reviewed by Chandel NS, 2010). The role of complex III activity in hypoxiainduced repression of PKCε has not been elucidated. The effect of complex III
antagonists (i.e. Stigmatellin, myxothiazol) on hypoxia-induced ROS production and
repression of PKCε expression is an interesting question that deserves further study. If
the mitochondria were the primary producer of ROS, then the attenuation of
mitochondrial derived ROS would answer multiple questions pertaining to the signaling
events initiating PKCε gene repression. Xanthine oxidase activity is another possible
player in hypoxia-induced PKCε repression. Kayyali et al (2001) demonstrated that
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hypoxia induced the phosphorylation and increased activity of xanthine oxidase.
Xanthine oxidase catalyzes the conversion of hypoxanthine to xanthine and xanthine to
uric acid (Harris CM et al., 1999). Xanthine oxidase preferentially uses molecular
oxygen as the electron acceptor thus producing superoxide radical. The effect of
blocking xanthine oxidase with allopurinol, a xanthine oxidase antagonist on hypoxia
induced repression of PKCε expression is interesting and deserves further study.
The exact mechanism of hypoxia-induced increase in methylation of the PKCε
promoter is yet to be elucidated. Hypoxia-induced hypermethylation of E-cadherin
promoter was reported to involve SNAIL transcription factor activity. SNAIL is
involved in the repression of epithelial specific genes such as occuludins, E-cadherin and
stimulating mesenchymal gene transcription (Reviewed by De Herreros et al., 2010).
Whether SNAIL activity is involved in hypoxia-induced repression of PKCε gene is an
intriguing question. Since both cocaine and nicotine have been reported to increase
oxidative stress, further understanding of SNAIL in hypoxia-induced repression of PKCε
may yield insight into a common pathway of intrauterine stress adaptation in fetal heart
cells.

Fetal Hypoxia and Cardioprotective Genes
The effect of maternal hypoxia on the expression of cardioprotective genes goes
beyond PKCε. Previous work in our lab has demonstrated maternal hypoxia causes a
reduction in the expression of endothelial nitric oxide synthase (eNOS) in adult offspring
(Li et al., 2003). NO plays an important role in maintaining normal vascular integrity.
While the cardioprotective role is controversial, with studies suggesting nitric oxide (NO)
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accumulation is important in ischemia reperfusion injury (Csonka, 1999) and others
showing NO to be protective (Boli, 2001), the use of gain of function/ lost of function
experiments in transgenic mice seem to suggest a strong correlation of NO in promoting
cardioprotection against ischemia reperfusion injury (Reviewed by Jones SP, 2006).
Interestingly, SP1 transcription factor is important for critical basal expression of eNOS
in endothelial cells (Zhang et al., 1995). Furthermore, mutation of Sp1 concensus
sequence at -104 of the eNOS promoter significantly reduced basal eNOS activity
(Kumar et al., 2008). The GC rich region at -104 contains two potential CpG dinucleotide
sequence at the core the binding motif (Kumar et al., 2008). The sequence is as follows
(-119 5′ATT GTG TAT GGG ATA GGG GCG GGG CGA G 3′ -92). Kumar et al.
(2008), was able to demonstrate H2O2 significantly reduces eNOS promoter activity by
decreasing SP1 activity. In addition, methylation of eNOS promoter plays an important
role in regulating cell specific expression of eNOS (Chan et al., 2004). Whether chronic
hypoxia directly regulates eNOS promoter through increase CpG dinucleotide
methylation of Sp1 binding sites in fetal hearts is intriguing and warrants further study.
Heat shock protein 70 (Hsp70) presents another interesting cardioprotective gene
that was reported to be sensitive to maternal hypoxia. Studies have shown chronic
maternal hypoxia significantly reduces protein and mRNA levels in fetal hearts (Bae et
al., 2003). The down regulation on Hsp70 gene persists into adulthood (Li et al, 2003).
Hsp70 plays an important role in protection against ischemia reperfusion injury and
injury due to heat shock (Snoeckx et al., 2001; Okubo et al., 2001 Jayakumar et al.,
2001). The amount of Hsp70 directly correlates with the degree of cardioprotection
conferred (Hutter et al., 1994). Our lab has demonstrated that chronic maternal hypoxia
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reduces the expression of Hsp70 and reduces recovery from heat shock in adult rat hearts
(Li et al., 2004). Morgan (1989) demonstrated Sp1 binding to Hsp70 promoter promotes
transcription activity. Interestingly, Morgan (1989) identified two Sp1 binding sites at
the proximal promoter (-172 to -163 and -50 to -41) that possess CpG dinucleotides in
their consensus sequence. Whether methylation of those binding sites reduces SP1
binding and Hsp70 promoter activity is an intriguing question. Whether those binding
sites are sensitive to chronic hypoxia in fetal hearts is interesting and warrants future
investigation.

Previous studies in our lab have shown prenatal hypoxia causes the increased
expression of β2AR and the ratio of Gsα/Giα. The functional significance of this finding
is not clear. However, studies in mice have shown overexpression of β2AR increased
contractility and ischemia reperfusion injury in male but not female hearts (Cross et al.,
2002). In addition, β2AR knockout mice showed reduce injury from middle cerebral
artery occlusion or wild-type mice pretreated with β2AR antagonist. Studies looking at
epigenetic modifications to the proximal promoter of β2AR gene are few, but recent work
done by McAlees et al. (2011) found that methylation of proximal promoter of β2AR
occurred in CD4+ T cells. Perhaps this region is sensitive to intrauterine stress in fetal
cardiomyocytes, resulting in changes in methylation patterns for β2AR gene leading to
enhanced vulnerability to ischemia reperfusion injury.
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Conclusion
The findings from this study demonstrate chronic hypoxia directly regulates
PKCε expression in fetal hearts through increase methylation of two Sp1 binding sites
located at the proximal promoter. The mechanism initiating the epigenetic modification
of PKCε promoter involves the elevation of ROS but does not require HIF-1α nuclear
accumulation. Our findings contribute significant understanding to the processes
involved in fetal programming. Indeed, the methods used to elucidate PKCε regulation in
the context of the developing myocardium may be applied to other tissues. The effect of
chronic intrauterine hypoxia on cardioprotective, neuroprotective, and tumorigenic genes
may shed new understanding that will allow for future interventions, which may protect
against the onset of adult diseases.
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